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Abstract 
Infection characteristics of Salmonella enterica serovar Brandenburg in vitro 
 
by 
Feng Piao 
 
Salmonella enterica serovar Brandenburg (S. Brandenburg) is primarily recognized as a 
pathogenic agent causing acute diarrhoea in humans and livestock. In New Zealand, it also 
causes abortion and septicaemia, particularly in pregnant ewes. The disease outcome and 
severity may depend on serovar- and host-specific factors. In this study, the uptake and 
persistence characteristics (adhesion, invasion and replication) of selected S. Brandenburg 
isolates were investigated, using primary cell cultures derived from ovine and bovine oviduct 
and intestine, in an attempt to help explain why the agent is so pathogenic in sheep.  
In the first study, different profile 14 (epidemic) S. Brandenburg isolates 3684, 3062 and 4468 
and non-profile 14 S. Brandenburg isolate 4527 were added into ex vivo and in vitro cell 
cultures derived from sheep oviduct. In three independent assays adhesion, invasion and 
replication were measured at 1, 2, and 24 h respectively. In the second study, ex vivo or in 
vitro cell cultures from sheep oviduct were infected with either S. Brandenburg isolate 3684 
or S. Typhimurium isolate 1979 and adhesion, invasion and replication characteristics were 
compared. In the third study, S. Brandenburg isolate 3684 was added to ex vivo and in vitro 
the ovine oviduct epithelial cell (OOEC) or bovine oviduct epithelial cell (BOEC) cultures 
and same time course measurements were made. In the fourth study, S. Brandenburg isolate 
3684 was added to in vitro cell cultures derived from either ovine intestine cells (OIECs) or 
ovine oviduct cells (OOECs) and the same time course measurement were compared. 
Bacterial counts were estimated after 10 fold serial dilution onto LB agar plates and overnight 
incubation at 37
o
C. The adhesive, invasive and replicative characteristics of the different 
Salmonella isolates were compared using a Student two-sample t-test. 
S. Brandenburg profile 14 isolates 3062, 3684, 4468 shared similar adhesive, invasive and 
replicative capabilities in both ex vivo and in vitro OOECs. Invasion of non-profile 14 isolate 
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4527 was less than profile 14 isolates 3684, 3062 and 4468 in both ex vivo and in vitro 
OOECs (P<0.01). Secondly, S. Brandenburg isolate 3684 more readily adhered to, and 
replicated within, OOECs than S. Typhimurium isolate 1979, in ex vivo OOECs (P<0.01). 
Thirdly, S. Brandenburg isolate 3684 more readily replicated within OOECs (P<0.01) than 
BOECs in both ex vivo and in vitro assays. Fourthly, S. Brandenburg isolate 3684 more 
readily invaded and replicated within in vitro OOECs than OIECs (P<0.01).  
Together, these results suggest that S. Brandenburg profile 14 isolates share some phenotypic 
characteristics regarding infection and suggest that virulence of S. Brandenburg in vivo is 
associated with its infectivity characteristics in vitro and ex vivo. In addition, the 
characteristics of S. Brandenburg field infections in sheep may be due to its preference for 
infecting in vitro OOECs, not BOECs or OIECs. 
Keywords: S. Brandenburg, pregnant ewes, abortion, adhesion, invasion, replication, ovine 
oviduct epithelial cells (OOECs), bovine oviduct epithelial cells (BOECs), ovine intestinal 
epithelial cells (OIECs). 
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     Chapter 1 
Introduction 
During the 1990s, Salmonella enterica serovar Brandenburg (S. Brandenburg) was recognized 
as a causative pathogen of late pregnancy abortion and death amongst sheep in New Zealand. 
One year later, the organism had spread into dairy cattle and beef cattle herds, causing 
diarrhoea, dysentery, abortion and death with a lower prevalence and less commonly also in 
other species such as horse, dogs, goats, pigs and deer (Clark, et al., 2000; Higgan, et al., 
2001). An average lambing loss of 17% on affected farms was recorded throughout the 
southern region of the South Island of New Zealand during the disease peak between 2000 
and 2005 (Boxall, et al., 1999). 
Ingestion of Salmonella is one of the predominant entry points for subsequent illness 
(Tannock & Smith, 1971). Salmonella express a range of mechanisms to survive and pass 
through the host gut, such as tolerance to the low pH conditions in the stomach, resistance to 
the components of digestion and competition with established microorganisms allowing 
penetration and colonization (Baumler, et al., 2000). Salmonella may reach the small 
intestine, penetrate the intestinal wall, multiply in the gut-associated lymphoid tissue (GALT) 
of the sub-mucosa and Peyer‘s patches (Carter & Collins, 1974; Samuel, 1981) and trigger 
mucosal inflammation and diarrhoea. Some serovars such as S. Typhimurium are confined to 
the intestine and only damage the alimentary tract whereas others such as S. Brandenburg can 
migrate into the mesenteric lymph nodes, spread via the efferent lymphatic vessel through the 
thoracic duct into the blood stream and be carried further to the liver, spleen and reproductive 
tract, eventually causing abortion in sheep and cattle (Baumler, et al., 2000).  
The mechanism by which the serovar Brandenburg causes abortion in sheep and cattle in New 
Zealand still remains unknown. However, the infection characteristics of the microorganisms 
including adhesion, invasion, survival and replication may play important roles in the process 
of infection and may influence reproductive outcomes. 
The literature review firstly describes the disease caused by S. Brandenburg. Secondly, the 
characteristics of Salmonella such as taxonomy, antigenic specificity, biochemical properties 
and genetic basis to virulence will be reviewed. Thirdly, the mechanisms of innate and 
specific response to Salmonella will be compared. 
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While important findings revealing the interaction between S. Brandenburg and sheep have 
been documented in recent years, the mechanism of abortion caused by S. Brandenburg is still 
poorly understood. Recent New Zealand research on S. Brandenburg has focused on the 
comparison of genomic sequences from S. Typhimurium and S. Brandenburg to identify 
potential genes responsible for S. Brandenburg virulence (Brandt, et al., 2008). There remains 
a need to understand the mechanisms underlying host specificity for S. Brandenburg and why 
does S. Brandenburg but not S. Typhimurium typically cause reproductive disease in New 
Zealand.  
Therefore, this research had four hypotheses:  
1. That S. Brandenburg isolates differ in their infective abilities for ovine oviduct epithelial 
cells. 
2. That ovine oviduct epithelial cells are more ‗susceptible‘ to infection by S. Brandenburg 
than S. Typhimurium. 
3. That ovine oviduct epithelial cells are more ‗susceptible‘ to infection with S. Brandenburg 
than bovine oviduct epithelial cells. 
4. That ovine oviduct epithelial cells are more 'susceptible' to infection by S. Brandenburg 
than ovine intestinal epithelial cells. 
These research objectives would be addressed by assessing the infection characteristics of 
Salmonella such as adhesion, invasion and replication in primary cultures of oviduct or 
intestinal epithelial cells. 
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     Chapter 2 
Literature review 
2.1 Historical prevalence of S. Brandenburg  
S. Brandenburg is a Gram negative, facultative intracellular bacterium which has been 
recognized as causative of an emerging zoonosis in New Zealand. In the early 1930s, the 
bacterium was first isolated from a human case in a town in Germany called Brandenburg 
(Kauffmann & Mtsui, 1930). In New Zealand, S. Brandenburg was first isolated from a 
sewage swab in 1966 and subsequently from cases of human gastroenteritis (Clark, et al., 
2004). In 1996, S. Brandenburg was isolated from an aborted foetus in a Merino ewe in 
Canterbury (Bailey, 1997). Soon after that the disease was recognized as a causative pathogen 
of late pregnancy abortions and deaths amongst sheep in the South Island of New Zealand. 
One year later, the organism had spread into dairy cattle and beef cattle herds and less 
commonly in other species such as horses, dogs, goats, pigs and deer, causing diarrhoea, 
dysentery, abortion and death (Clark, et al., 2000; Higgan, et al., 2001).  
Infections due to S. Brandenburg can be found worldwide, but it has been most common in 
the developed countries, such as Germany (Kauffmann & Mtsui, 1930), England (Jones, et 
al., 1964) Switzerland (Baquar, et al., 1994), France (Lamisse, et al., 1971), Spain (Curbelo, et 
al., 1954), Italy (Scuderi, et al., 2000), Belgium (van Looveren, et al., 2001), Hungary (Rowe, 
1987), Australia (Murray & Davos, 1995), New Zealand (Bailey, 1997) and Japan (Hamada & 
Tsuji, 2001).  
2.1.1 Human S. Brandenburg infections in New Zealand 
In New Zealand, S. Brandenburg has historically been an uncommon cause in human 
infections, and has accounted for only 142 (1%) of the 14,000 salmonellosis case isolates 
serotyped between 1985 and 1994. From 1985 to 1989 there were 68 viable human isolates of 
S. Brandenburg and 74 cases between 1990 and 1994 (Baker, et al., 2007; Wright, et al., 
1998).  
However between 1995 and 2001, non-typhoidal salmonellosis had increased in New 
Zealand, peaking at 2417 cases in 2001 of which 137 cases were due to S. Brandenburg, with 
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5.1% of the cases occurring in the Auckland-Waikato region and 69% in the Otago-Southland 
region. 
From 2002 to 2010, the number of salmonellosis cases due to S. Brandenburg in humans 
decreased to an average 57 human cases per year (Figure 2.1).  
 
Figure 2.1 Incidence of human infection in New Zealand due to S. Brandenburg 
(Thornley, 2002; Wright, et al., 1998). 
  
Years
1980 1985 1990 1995 2000 2005 2010 2015
N
u
m
b
er
 o
f 
ca
se
s 
o
f 
S
. 
B
ra
n
d
en
b
u
rg
 i
n
 h
u
m
a
n
s
0
20
40
60
80
100
120
140
160
180
17 
 
2.1.2 Non-human S. Brandenburg infections in New Zealand 
Prior to 1996, S. Brandenburg was rarely found in non-human sources (Wright, et al., 1998). 
In 1996, S. Brandenburg was recorded from a foetus aborted from a sheep in Canterbury, New 
Zealand (Bailey, 1997). Subsequently, in 1998 the microorganism caused outbreaks of 
abortion and death in sheep in Mid- and South Canterbury, South- and West Otago, and 
Southland (Boxall, et al., 1999; Clark, et al., 2000; Roe, 1999). One year later, the organisms 
had spread into dairy and beef cattle herds, causing diarrhea and dysentery in adult cattle and 
calves, abortions and deaths in first calvers, and to a lesser extent in second calvers (Clark, 
2001; Clark, et al., 2000). The epidemic curve in sheep and cattle in New Zealand illustrates 
the lower prevalence of S. Brandenburg in cattle compared with that in sheep (Figure 2.2). 
 
Figure 2.2 Number of New Zealand farms with disease caused by S. Brandenburg 
(Clark, 2001). 
The majority of cases of infection with S. Brandenburg occurred in the winter or spring period 
and primarily in pregnant ewes. Data from farms that had harboured S. Brandenburg 
identified an abortion prevalence of 6%-20% in two-tooth ewes and 3% in mixed-aged ewes. 
The fatality rate following abortion in the pregnant ewes was typically around 50%, but 
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reached 100% on certain farms (Clark, et al., 2004). In the field, S. Brandenburg is less 
virulent in non-pregnant ewes with a smaller number of deaths recorded following clinical 
signs such as diarrhoea, and dysentery but at high experimental doses is lethal (Li, et al., 
2005).  
2.2 Transmission   
Although it is still not clear how and where S. Brandenburg originated in New Zealand, 
subsequent spreading of these bacteria by environment contamination has been considered to 
play a critical role in prevalence of the salmonellosis due to it today. The primary infective 
pathway for spread is believed to be ingestion of microorganisms and subsequent colonization 
in the gastrointestinal tract (GIT) (Clark, et al., 2000). Furthermore, sheep can be also infected 
via inhalation of low doses of Salmonella organisms (Tannock & Smith, 1971). Since 
asymptomatic sheep have been shown to excrete S. Brandenburg in faeces for up to 6 months 
(Li, et al., 2005), contamination of the environment continues for a long time. The organisms 
can also spread in aborted foeti placenta and uterine discharges excreted by infected animals 
(Hunter, 1990). Epidemiological surveys showed that wild scavenging birds such as black-
backed gulls (Larus dominicanus) are likely to be vectors of salmonellosis following 
ingestion of aborted foetuses or dead ewes (Clark, et al., 2004). It was found that S. 
Montevideo (Coulson, et al., 1983) and S. Brandenburg (Clark, et al., 2004) could multiply in 
the intestinal contents of gulls and were shed at high levels in their faeces. Farm workers or 
equipment may act as fomites for the transfer of Salmonella; similarly healthy persons 
infected with Salmonella may be carriers for the bacteria (Kotova, et al., 1988).  
2.3 Clinical signs and pathological lesions of Salmonella Brandenburg 
infections 
Pathology caused by S. Brandenburg varies amongst different hosts. In humans, S. 
Brandenburg is usually restricted to gastroenteric disease, which will lead to typical clinical 
signs such as severe diarrhoea, abdominal pain, stomach cramps and fever, which may last for 
up to six weeks (Clark, et al., 2004). However, S. Brandenburg has also been reported as a 
pathogen of extra-intestinal diseases such as a thigh abscess in Sweden (Bjorkman, et al., 
2002), suppurative thyroiditis and abscess of ovaries in Italy (Chiovato, et al., 1993; Magliulo, 
1982), peritonitis and septicaemia in France (Lamisse, et al., 1971; Laurens, et al., 1991), 
aortic aneurysm and manubriosternal junction osteomyelitis in the United Kingdom (Bliss, et 
al., 1968; Chattopadhyay, et al., 1990) and urinary tract infection in Germany (Adam & 
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Daschner, 1973). In New Zealand, extra-intestinal diseases due to infections with S. 
Brandenburg in human have included pericarditis, bacteraemia and pneumonia (Clarke & 
Tomlinson, 2004).  
In animals, infections due to S. Brandenburg typically cause gastroenteric disease. Diarrhoea 
is one of the most common clinical signs among infected animals. In addition to the intestinal 
disorders, in areas of the South Island of New Zealand, S. Brandenburg has caused abortion 
and often subsequent death in pregnant ewes but it is less common in cattle. S. Brandenburg 
infection is common during the winter-spring season which is different from other Salmonella 
serovars (Robinson, 1970). The infection usually affects pregnant ewes from around the 80
th
 
day of gestation, peaking about 100-120 days gestation (Clark, et al., 1999; Smart, 2000). 
Experimentally infected ewes given 10.3 log10 CFUs become depressed and anorexic after 2 
days and especially those with multiple foeti may abort and die (Li, et al., 2005). In peracute 
cases the uterus of ewes will enlarge and darken (Clark, et al., 2007) and the expelled foetuses 
commonly have a ‗cooked‘ appearance with swollen liver, blood tinged stomach contents, 
oedematous subcutaneous tissue and characteristic putrid smell (Figure 2.3).  
Histological examination of placental samples showed that the capillaries of the placenta were 
packed with numerous S. Brandenburg that might trigger inflammatory reactions in the 
placental chorion, resulting in dysfunction of placenta and abortion or death of the foetus 
(Clark, et al., 1999). 
 
Figure 2.3 Abortion and death caused by S. Brandenburg (Clark, et al., 2004). 
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2.4 Disease control 
Several approaches are recommended with regard to controlling the transmission of 
salmonellosis, including the use of vaccine, antibiotic treatment and changes in farm 
management.  
Salvexin+B, a vaccine that is commercially available in New Zealand and produced by 
Intervet/Schering-Plough New Zealand contains antigens from the four most common 
serovars of Salmonella (i.e. S. Typhimurium, S. Bovismorbificans, S. Hindmarsh and S. 
Brandenburg) (Marchant, 2000). Even though a such vaccine can reduce the incidence of 
abortion and death caused by S. Brandenburg, only partial protection is evident under high 
challenge (Kerslake & Perkins, 2006; Li, et al., 2005) and is not in common use even in 
regions where the disease is present (Hicks, 2006). A recent study reported that a semi-
purified subunit vaccine is likely to be superior to this commercial available vaccine, at least 
with experimental infections (Li, et al., 2005). 
Antibiotic treatment is another approach for sheep farmers to protect sheep stock from an 
outbreak of this disease. Antibiotic sensitivity testing in sheep showed that S. Brandenburg is 
sensitive to many antimicrobial drugs including ampicillin, cephalothin, enrofloxacin, 
streptomycin, tetracycline, ciprofloxacin, nalidixic acid and trimethoprim, but resistant to 
lincomycin and penicillin (Clark, et al., 2004; Wybot, et al., 2004). Mass treatment of flocks 
has been attempted successfully in the field (Smart, 2000). However, the disadvantage of 
using antibiotics widely is the increasing risk of developing new strains which are multi-drug-
resistant (Poppe, et al., 1998). 
A change in farm management may reduce the risk of occurrence and severity of the disease. 
There are a number of preventative and control measurements, such as, rapid disposal of 
aborted foetuses, isolation of aborted ewes, reduction in stress levels for pregnant ewes, 
control of scavengers, cleaning and disinfection of vehicles and care in buying sheep (Clark, 
et al., 1999). Break feeding (or strip grazing) is a common grazing system for sheep in New 
Zealand. Such a method keeps large numbers of stock on a small area with an electric fence 
and as a result high levels of environmental contamination with S. Brandenburg occur 
(Kerslake & Perkins, 2006). Destocking or allowing animals to graze over larger areas 
reduces the risk of disease.  
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2.5 Characteristics of Salmonella 
2.5.1 Taxonomy of Salmonella 
The taxonomy of Salmonella is complex and has been revised several times over the years 
(Kauffmann & Edwards, 2005; Tindall, et al., 2005). At present, the genus consists of three 
species, which are S. bongori, the recently identified S. subterranea (Shelobolina, et al., 2004) 
and S. enterica as described by Baumler (1997) (Figure 2.4). S. enterica can be subdivided 
into six subspecies that are subdivided into serovars according to their classical antigenic 
composition. S. enterica ssp. enterica (I) includes most clinically relevant serovars accounting 
for 99% of all known salmonellosis in warm blooded hosts. One example is S. Brandenburg 
that can be described in this group as Salmonella enterica serovar Brandenburg or Salmonella 
enterica subsp. enterica serovar Brandenburg. Identification of Salmonella subspecies are 
also based on antigenic specificities, biochemical properties and genetic analysis (Le Minor & 
Popoff, 1987). 
2.5.2 Antigenic specificities  
Salmonella possesses three main antigens: flagellar antigen (H) somatic antigen (O) and 
capsular or virulence antigen (VI). Serological analysis of O and H antigens was initiated by 
White (1926) and extended by Kauffmann (1966). The H antigen is heat labile and contains 
proteinaceous flagellins. The O antigen is a heat stable antigen which is composed of 
phospholipid-polysacharide complexes (Kauffmann, 1966). While the VI antigen is a capsular 
polysaccharide overlying the O antigen, it is present in only a few serovars, e.g. S. Typhi and 
S. paratyphi C (Felix & Pitt, 1936). 
The subspecies are divided into over 50 serogroups based on somatic (O) antigens present. 
The serogroups are further divided into over 2300 serotypes based on flagellar (H) antigens. 
Currently, there are approximately 2400 specific serovars that have been identified, based on 
the Kauffmann-White antigenic scheme. These organisms are recorded by genus and serotype 
(or serogroup). The serotype formula for S. Brandenburg is somatic (O) antigens 1,4, [5], 12, 
27 and flagella (H) antigens phase 1:1, v and phase 2:e, n, z15 (Bjorkman, et al., 2002). This is 
similar to the somatic antigens of S. Typhimurium (O antigen: 1,4,5, 12) (McWhorter-Murlin 
& Hickman-Brenner, 1994). 
 
  
2
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Figure 2.4 Dendrogram of Salmonella classification (Baumler, 1997). 
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2.5.3 Biochemical properties 
Strains of S. enterica have the following properties which are typical of the family 
enterobacteriaceae. Salmonella enterica do not produce indole or ferment glucose by the 
mixed acid fermentation. Unlike other serovars, S. Brandenburg does not produce 
phenylalanine deaminase or urease, but it does utilize citrate as sole carbon source, and 
produce hydrogen sulfide (H2S). It is motile and ferments a variety of carbohydrates and 
decarboxylate arginine, lysine and/or ornithine (Le Minor, et al., 1970; Le Minor & Popoff, 
1987). 
2.5.4 Genotypic analysis 
A bacterial species can be defined as a DNA hybridization group. Strains within a species are 
generally more than 70% related (Wayne, et al., 1987). DNA hybridization studies (Crosa, et 
al., 1973; Le Minor, et al., 1982; Stoleru, et al., 1976) have classified the genus Salmonella 
into only three genomic species, S. enteric, S. bongori and S. subterranean (see 2.5.1).  
Furthermore, the multilocus enzyme electrophoresis (MLEE) method has been used to assess 
allelic variation in multiple genes among Salmonella isolates. This analysis indicates that S. 
bongori is the most divergent group of Salmonella. In S. enterica subsp. enterica, MLEE 
analysis shows serovar Typhi as a single clone, distinct from all other serovars studied. 
Serovars Paratyphi A and Sendai are in a group, whereas serovars Typhimurium, Paratyphi B, 
Saintpaul, Heidelberg and Muenchen harbour a loose cluster. MLEE analysis has identified 
serovar Enteritidis as a close relative of serovar Gallinarum (Selander, et al., 1996). Aside 
from MLEE, pulsed field gel electrophoresis (PFGE) was used to type S. Brandenburg 
isolates in New Zealand. Macro-restriction fragment length polymorphism (MRFLP) analysis 
revealed 13 different patterns typed from human isolates recovered between 1990 and 1995 
(Wright, et al., 1998). In 1999,  a different but identical molecular pattern was seen in all 
isolates from 14 sheep, 19 cattle and one dog. In 2000, 45 sheep-yard dust isolates were typed 
and, with one exception, all had the same molecular pattern termed profile 14. The DNA 
pattern from the exceptional isolate provided the first evidence of diversion from the S. 
Brandenburg sheep abortion epidemic strain (Clark, et al., 2003). 
2.6 Virulence mechanisms of Salmonella and infection progression 
The basic virulence strategy of Salmonella is complicated, which involves several critical 
stages in terms of crossing the epithelial lining of the small intestine, reaching the blood 
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stream, disseminating further into the reticuloendothelial system of the host, inducing 
macrophage apoptosis and host death. 
Salmonella are enteroinvasive bacteria that typically gain entry to the gastrointestinal tract via 
contaminated food or water; most bacteria are killed in the stomach or passed out of gut. The 
alimentary tract is a hostile environment, which imposes multiple stresses upon invading 
bacteria. The first host defence is the acid barrier of the stomach for oral infections (Bearson, 
et al., 1997). Although this acid environment inactivates many bacteria, Salmonella may 
survive. For example, Carter and Collins (1974) found that 1% of S. Enteritidis inoculum can 
survive in a low pH environment during the passage through the stomach.  
Within the small intestine, Salmonella encounter the action of bile salts which are detergents 
made by the liver and secreted into and stored in high concentrations in the gallbladder. Bile-
containing salts are released into the intestine to aid in the dispersion and degradation of fats. 
Enteric bacteria, including Salmonella, are resistant to the effects of bile, a finding that has 
been used clinically in the selective enrichment of these organisms (van Velkinburgh & Gunn, 
1999). Like other enterobacteria, some Salmonella serovars are well adapted to cope with this 
stress condition and gain a foothold at the preferred niche in the intestinal wall, the gut-
associate lymphoid tissue (GALT). For example, it was found that during infection of mice 
with S. enteritidis, about 5% of the bacteria that survive the passage through the stomach 
manage to penetrate the intestinal wall of the small intestine and reach the GALT (Carter & 
Collins, 1974).  
The indigenous gut flora is another important factor that can inhibit colonization by these 
serovars; known as bacterial interference. Several mechanisms of bacterial interference have 
been proposed, including production of inhibitory substances, competition for tissue adhesion 
sites and limiting of nutrients. The primary site of intestinal invasion is the distal ileum where 
some Salmonella effector proteins are involved in translocation into host cells to drive their 
own uptake. In mammals, lymph follicles are clustered as Peyer‘s patch typically where 
Salmonella enter.  
Follicle-associated epithelium (FAE) overlying Peyer‘s patches contains microfold cells (M 
cells) (Figure 2.6) which are not found in villous epithelium (Giannasca, et al., 1994; Pappo & 
Owen, 1988).  
Although M cells are involved in maintaining immune response at the different sites of 
MALT, numerous bacteria such as Salmonella selectively adhere to, and efficiently pass 
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through, both enterocytes and M cells enriched within the FAE, as well as other epithelial 
cells (Mastroeni & Sheppard, 2004). For example, at an early stage of infection with S. 
Typhimurium, it has been noted that large membrane ruffles appear on the apical surface of 
the M cell and, within a short period of time (30-60 min), the cell becomes necrotic and 
begins to die (Clark, et al., 1994) (Figure 2.6). M cells are usually surrounded by lymphocytes 
and this association provides a direct interaction for antigen presentation. An alternative 
mechanism of invasion, independent of M cells, is where Salmonella is engulfed by dendritic 
cells (DCs) that open the tight junctions between epithelial cells through tight-junction 
proteins and directly sample bacteria (Rescigno, et al., 2001).  
Having traversed the intestinal mucosa, Salmonella drains to the regional lymph nodes, where 
macrophages that line the lymphatic sinuses form an effective barrier to prevent further spread 
(Figure 2.5). If the bacterial extension is limited at the regional lymph nodes, infection 
remains within the intestine and only causes localized disease with diarrhea, a typical sign of 
disease (Baumler, et al., 2000). On the other hand, if the macrophages draining the lymph 
nodes are not able to limit spread, systemic disease can ensue. During systemic infection, the 
pathogens spread via the efferent lymphatics and the thoracic duct into the vena cava and 
eventually seed the filtering organs of the reticuloendothelial system (RES)-liver and spleen. 
A microscopic examination revealed that in liver, the initial lesions appeared at early stage of 
infection with masses of infiltrating neutrophils accumulated in well defined necrotic foci. 
Macrophages began to appear in the periphery of lesions in the following days, replacing the 
neutrophils, since neutrophils are short-lived (Conlan, 1997). During the late stage of 
infection the macrophages were not only present in the foci, but also in large numbers in the 
interstitial area of the parenchyma causing leucostasis of the liver. Similarly in spleen, the 
majority of infected splenocytes are surrounded by neutrophils at an early stage of infection. 
However; Salmonella are localized to specific subsets of marginal zone and red pulp 
macrophages at the late stage of infection (Salcedo, et al., 2001; Thone, et al., 2007). It is 
clear that massive numbers of Salmonella organisms are phagocytosed by macrophages and 
DCs. However, rather than being destroyed by these phagocytes upon engulfment, Salmonella 
has evolved several mechanisms to survive in the harsh milieu of phagosomal compartments 
(Foster & Spector, 1995). For example, Rathman et al. (1997) found that approximate 75% of 
S. Typhimurium can bypass the fusion of phagosomes with lysosomes by diverging from the 
normal endocytic trafficking pathway of the host cells. Although, very little information upon 
the mechanism can be obtained, it has been widely accepted that Salmonella can survive and 
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even replicate within macrophage phagososmes and be cytotoxic to macrophages by inducing 
apoptosis in vitro (Chen, et al., 1996; Maw & Meynell, 1968; Monack, et al., 1996).  
The cytotoxicity manifests itself in at least two different ways: initial impairment of the 
ruffling and macro-pinocytic activities of the infected macrophages in which the infected 
macrophage begin to ‗round followed by death of the infected macrophages. During this time, 
Salmonella organisms exhibited several features of apoptotic cells such as membrane 
blebbing, typical chromatin condensation and fragmentation with the presence of apoptotic 
bodies (Chen, et al., 1996). Cytotoxic effects are dependent upon the expression of the T3SS 
(See section 2.7.5). At the end of this phase, bacteria reappear in the blood and replicate 
rapidly until the animal dies. Death may result from endotoxic shock (Khan, et al., 1998). 
 
Figure 2.5 A diagram illustrating the events leading to establishment of Salmonella 
infection of Peyer’s patch in mouse (Jepson & Clark, 2001). 
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2.7 Virulence factors 
Establishment of Salmonella infection relies on virulence factors (molecules expressed and 
secreted by the pathogens) which enable them to colonize at a niche site in the host, evade the 
host‘s immune response, provide entry into and exit out of cells and obtain nutrition from the 
host. The ability of Salmonella to attach to the intestinal epithelium is attributed to a number 
of virulence factors that are related to the bacterial cell wall components such as fimbriae, 
flagella, endotoxins and outer membrane proteins.  
2.7.1 Fimbria  
A fimbria is a proteinaceous appendage found in Salmonella strains of which five types have 
been characterized (Thorns, 1995). Fimbriae are thought to enhance the ability of the bacteria 
to colonize and adhere to specific host target tissues in the early stages of infection. For 
example, serovars Gallinarum and Pullorum expressing S. enterica serovar Typhimurium type 
1 fimbriae exhibited an increased ability of attachment and invasion efficiency to the human 
epithelial cells (Wilson, et al., 2000). Hence, fimbriae contribute to virulence. Darekar and 
Duguid (1972) found that the fimbriated S. Typhimurium caused more infections (+26%) and 
death (+40%) than the non-fimbriated strains in orally inoculated mice.  
2.7.2 Flagella 
Flagella are long, thread-like appendages which provide Salmonella with the ability to move, 
which increases the probability that they will reach suitable sites for invasion. In most 
serovars of Salmonella, flagella alternate between two distinct antigenic structures referred to 
as phase 1 and phase 2 encoded by the fliC and fliB genes respectively (Schmitt, et al., 2001). 
Flagella actively mediate the initial interaction between the bacterium and host cell and 
Salmonella mutants without flagella have reduced colonization capability in the 
gastrointestinal tract. Passive antibody activity directed against Salmonella flagella conferred 
protection from experimental salmonellosis in mice when administered orally using chicken 
egg yolk antibodies specific for Salmonella (Yokoyama, et al., 1998). 
2.7.3 Toxin 
Salmonella produce both exotoxins and endotoxins. The exotoxins can be further divided into 
two groups: cytotoxins and the enterotoxins. The major toxins of Salmonella causing 
intestinal and systemic infections are conferred by endotoxins that are an integral part of the 
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bacterial cell wall (van Asten & van Dijk, 2005). Gram-negative bacteria endotoxins are 
broadly represented by lipopolysaccharide (LPS) and elicit their toxic affect after attachment 
to cell-associated extracellular receptors. The O antigen component of LPS is not only 
immunogenic but also is virulent to the host by evasion of the innate host defences. During 
invasion of the gut, Salmonella organisms use LPS as a ligand mediating the internalization of 
bacteria by epithelial cells (Lyczak, et al., 2001). 
2.7.4 Outer membrane proteins (OMPs) 
In severe cases, Salmonella can spread from the gut, the site of infection, to cause a systemic 
disease. These pathogens must possess a number of virulent factors that help them to evade 
the host‘s defences, in addition to fimbriae, flagella and LPS. These virulent components are 
defined as outer membrane proteins (OMPs) which are most frequently associated with 
systemic infections (Valone & Chikami, 1991).  
Porin is a trimer protein encoded by Omp C, Omp F and Omp D genes. Studies have revealed 
that proteins, especially porins, have been implicated in host defence mechanisms (Tabaraie, 
et al., 1994). Porins inhibit phagocytosis by activating the adenylate cyclase system (Di 
Donato, et al., 1986). They have also been found to induce a dose-related oedema following 
injection into the rat paw, due to release of a histamine from peritoneal cells (approx 5% mast 
cells) (Galdiero, et al., 1990). Specific immune responses directed against Salmonella derived 
OMP, extract and purified proteins have been shown to protect various animals from animals 
from salmonellosis (Li, et al., 2005; Meenakshi, et al., 1999; Ochoa-Reparaz, et al., 1996; 
Tabaraie, et al., 1994). 
2.7.5 Other virulence factors 
Establishment of Salmonella infection relies on virulence of the bacteria, which is encoded by 
Salmonella-specific virulence genes. These genes play important roles in both intraperitoneal 
and intravenous infections. Many effector proteins are encoded in pathogenicity islands (PI) 
which are large chromosomal DNA fragments contributing to virulence of Salmonella 
through changes in attachment, invasion, survival and replication within host cells (Ehrbar & 
Hardt, 2005; Hacker & Kaper, 2000). 
Type III secretion system (T3SS) is composed of a protein appendage found in Salmonella 
serovars that acts as a ―molecular syringe‖ to inject effector proteins directly into the host cell 
cytoplasm, where the proteins manipulate host cell signalling (Galan, 2001). So far 
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approximately 30 different genes have been characterized to comprise the T3SS. Priority has 
been given to two groups of genes in the Salmonella genome encoding for the T3SS; 
Salmonella Pathogenicity Island 1 (SPI-1) and Salmonella Pathogenicity Island 2 (SPI-2).  
The Salmonella pathogenicity island 1 (SPI-1) gene is a major genomic locus which is 
responsible for intestinal penetration. It is acquired by plasmid or phage mediated horizontal 
gene fragment and is not found in E. coli or related organisms (Figure 2.4). Although SPI-1 
contains invasion genes for the uptake of Salmonella into epithelial cells and the subsequent 
induction of intestinal epithelial cell signals that lead to an inflammatory response (Galan, 
1996; Galyov, et al., 1997), it only contributes to the enteropathogenic stage of the infection, 
but is not required for systemic disease (Figure 2.7) (Galan, 1996; Wood, et al., 1998). In 
contrast to SPI-1, SPI-2 is essential for Salmonella survival and replication in systemic 
infections. Molecular analysis indicated that the effector proteins of SPI-2 T3SS are found in 
S. Enterica but not S. Bongori. Although the pathogenic mechanism is still under the 
investigation, some of effects of SPI-2 T3SS have been widely accepted. For example, it is 
known that SPI-2 confers on Salmonella the ability to survive and proliferate up to 10 fold 
within macrophages and host epithelial cells (Figure 2.7) (Cirillo, et al., 1998; Hensel, et al., 
1998; Ochman, et al., 1996; Vazquez-Torres, et al., 2000). Interference with normal 
intracellular trafficking inhibits maturation of Salmonella-containing phagosomes to phago-
lysosomes, measured in an in vitro assay. Moreover, SPI-2 is required to exclude 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase from Salmonella-containing 
vacuoles, allowing the microbe to escape oxidative death inside infected phagocytes 
(Vazquez-Torres, et al., 2000). 
Some other genes such as lpf fimbrial operon also play a role in mediating bacterial adhesion. 
Fimbrial adhesion is encoded by lpf binding receptors which are expressed on the surface of 
host cells. The fimbrial adhesion can recognize and bind to the epitopes that are only present 
at apical membrane surface (Baumler, et al., 1996). 
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Figure 2.6 Salmonella enterica interaction with host cells. The function of the SPI-1-
encoded T3SS is required for invasion of host cells and onset of diarrhoeal 
diseases. In contrast, the function of the SPI-2-encoded T3SS appears to be 
restricted to intracellular Salmonella. (Hensel, 2000). 
2.8 Host specificity of Salmonella 
Currently, the species Salmonella enteric includes over 2500 closely related serovars. They 
are mainly associated with warm-blooded vertebrates and are responsible for most Salmonella 
infections in humans and domestic animals (Helm, et al., 2003; Uzzau, et al., 2000). 
Salmonella serovars differ in the range of host, such difference is referred to as serovar-host 
specificity (Uzzau, et al., 2001). Some Salmonella serovars are generalists, which mean they 
express wide ranging host infectivity, although their severity varies depending on the types of 
animal infected. For example, Salmonella enterica serovar Typhimurium (S. Typhimurium), 
usually causes a self-limiting gastroenteritis in human, while it can cause more serious 
systemic infections in hosts that are immunocompromised (Weinberger, et al., 2004). S. 
Brandenburg also infects many different host species (Clark, et al., 2004) but with varying 
pathology. Other Salmonella serovars are very restricted in their host range and display very 
narrow host infectivity and only cause systemic disease in one specific host. For instance, 
Salmonella enterica serovar Typhi (S. Typhi) is restricted to humans and causes systemic 
disease (typhoid fever). Salmonella enterica serovar Abortusovis (S. Abortusovis) is limited 
to infections in sheep (Edsall, et al., 1960; Pardon, et al., 1988).  
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Finally, some Salmonella serovars are host-adapted and express a differential capability of 
infecting particular hosts. They generally cause disease in one particular animal species, but 
may also cause disease in other animals under certain circumstances. For example Salmonella 
enterica serovar Dublin (S. Dublin) typically causes disease in cattle, but it can also infect 
humans, mice and sheep (Jack, 1971; Taylor, et al., 1982). 
2.9 Immune response to Salmonella infection  
The severity and outcome of a Salmonella infection depends on the virulent factors of 
antigens, the infectious dose, the genetic makeup and the host immunological status (Dunlap, 
et al., 1991; Richter-Dahlfors, et al., 1997) Both innate immunity (non-specific) and adaptive 
immunity (specific) play an important role to protect the host against Salmonella.  
2.9.1 Innate immunity  
The initial immune response to Salmonella infection is via the innate or non-specific immune 
system. It includes serum complement, and non-specific defence cells such as 
polymorphonuclear neutrophils, macrophages, and natural killer cells, which provide efficient 
‗front-line‘ defence against Salmonella invasion (Dietert, et al., 1991; Kogut, et al., 1994; 
Portnoy, 1992; Sharma & Schat, 1991). An important step to initiate the innate immune 
response against Salmonella is the recognition of the antigens on the bacterial surface, 
referred to as a pathogen–associated molecular pattern (PAMP). Upon infection, antigen-
presenting cells (APCs) such as macrophages and DCs express a family of pattern-recognition 
receptors called Toll-like receptors (TLRs) on their surface. These receptors recognize 
conserved molecular products derived from various classes of pathogens, including Gram-
positive and-negative bacteria, DNA and RNA viruses, fungi and protozoa (Werling & Jungi, 
2003). Ligation between PAMP and TLRs initiates a signalling pathway that can stimulate the 
host defences through the induction of reactive oxygen and nitrogen intermediates (ROI and 
RNI) (De Groote, et al., 1996; Shiloh, et al., 1999; Shiloh, et al., 1997; Umezawa, et al., 
1997). 
Early bacterial growth is controlled in the reticuloendotelial system (RES) by the innate 
immune gene Natural-resistance-associated macrophage protein 1 (NRAMP1 also designated 
S1c11a11) with the contribution of both macrophages and polymorphonuclear cells (Conlan 
& North, 1992; Hormaeche, 1979a, 1979b, 1979c; Hu, et al., 1997; O'Brien, et al., 1979; 
Vidal, et al., 1993). Activated macrophages play a very critical role in antimicrobial immunity 
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and are regulated by NRAMP1. One of its pleiotropic effects on macrophage function is to 
regulate expression of major histocompatibility class II molecules (Lang, et al., 1997; 
Vazquez-Torres, et al., 2000). During this stage, phagocytic cells control the growth of 
invading Salmonella by either reactive oxygen intermediates (ROI) which are generated by 
NADPH oxidase (phox) or reactive nitrogen intermediates (RNI) produced by the inducible 
nitric oxide synthase (iNOS). 
2.9.2 Adaptive immunity 
Adaptive immune responses are often regarded as the second level of host defence and are 
initiated when T- and B- lymphocytes recognize foreign antigens presented on APCs 
(Cuadros, et al., 2004). Cell-mediated immunity and humoral immunity are two fundamental 
adaptive mechanisms conferred by T- and B- lymphocytes, which play an essential role in the 
clearance of Salmonella. Plasma cells produce antibodies which protect the host against 
infection by interacting with the surface of infecting pathogens to prevent them from bacterial 
attachment and invasion amongst other things (McGhee, et al., 1992; Michetti, et al., 1992). 
This protective function of antibodies occurs with the extracellular stage of bacterial infection. 
For cellular immunity, thymus derived lymphocytes (T cells) normally exert their effect on 
mediating the infection course by serving as direct effectors or function regulators. These 
cells are grouped according to their function in the immune system; cytotoxic (Tc) or helper 
(Th) T lymphocytes. The Th cell population can be further divided into Th1 and Th2 based on 
the different cytokines they elicit (Mosmann, et al., 1986). The Th1 cell is the producer of 
IFN-γ and IL-2, which are main components in cell-mediated immunity (CMI), while the Th2 
cell produces interleukin-4 (IL-4), interleukin-5 (IL-5), interleukin (IL-6) and interleukin-10 
(IL-10) cytokines that affect the humoral immunity. Both T lymphocytes and cytokines are 
essential components for a protective immune. 
2.9.2.1 Cell-mediated immunity 
In lethal Salmonella infections, bacteria rapidly reach large numbers in the tissues and death 
occurs within a short time by endotoxin poisoning. In sublethal infections, exponential growth 
of the organisms is prevented by host-response suppression in the RES towards the end of the 
first week, resulting in a plateau phase. The host response relies on chemo taxis to attract 
bone-marrow-derived macrophages (Hormaeche, et al., 1990; Mastroeni, et al., 1991; 
Mastroeni, et al., 1994; Mastroeni, et al., 1993; Nauciel & Espinasse-Maes, 1992). They 
contribute to the formation of granulomas rich in mononuclear cells.  
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Furthermore, several mediators such as tumor necrosis factor alpha (TNFα), interferon-
gamma (IFN-γ), IL-12, and IL-18 contribute to this formation and are linked to the 
suppression of Salmonella growth in the tissue (Mastroeni, et al., 1999). Tumor necrosis 
factor alpha (TNFα) is constantly required for the control of virulent Salmonellae in the RES 
both in a sublethal primary infection in innately resistant mice and also in a secondary 
infection in innately susceptible mice immunized with a live vaccine, but may not be essential 
for bacterial clearance of avirulent organisms from the tissues (Galdiero, et al., 1993). 
Interferon-gamma (IFN-γ) or type II interferon, with a molecular weight of 19,150 kDa in 
sheep, is crucial for the activation of macrophage and plays an important role in cell-mediated 
immunity (Young & Hardy, 1995). Although IFN-γ is produced predominantly by T 
lymphocytes and natural killer (NK) cells, other types of cells, such as B cells, natural killer T 
(NKT) cells and professional APCs are also involved in IFN-γ production (Carnaud, et al., 
1999; Flaishon, et al., 2000; Frucht, et al., 2001; Gessani & Belardeli, 1998; Harris, et al., 
2000; Yoshimoto, et al., 1998).  
It has been revealed that IFN-γ expression is rapidly upregulated in the intestinal mucosa, 
Peyer‘s patches, mesenteric lymph nodes, spleen, liver and leukocytes in response to 
Salmonella infection in infected mice (Eckmann, et al., 1996; Ramarathinam, et al., 1991) and 
sheep (Li, et al., 2005). Neutralization of IFN-γ function with antibodies or ‗knockout‘ IFN-γ 
gene leads to increases of bacterial number and decrease of host survival in mice (Bao, et al., 
2000; Gulig, et al., 1997; Nauciel & Espinasse-Maes, 1992). On the contrary, elevated IFN-γ 
levels in the circulation can inhibit the bacterial growth and improve the number of mice that 
survive. Although IFN-γ can exert its effects in both phagocytic and non-phagocytic cells, the 
major way for IFN-γ to control Salmonella infection is by activating macrophages in order to 
kill Salmonella and improving the presentation to lymphocytes via the major 
histocompatibility complex (MHC). In addition, Kagaya et al. (1989) pointed out that 
activated macrophages can develop the ability to secrete reactive oxygen intermediates (ROI), 
as well as to kill non-specific facultative intracellular microorganisms and a variety of 
neoplastic cells when they are exposed to recombinant IFN-γ (rIFN-γ). The cytokines IL-12 
and IL-18 play a protective role in host defence against invasion of Salmonella (Dybing, et 
al., 1999; Mastroeni, et al., 1999). This effect is likely to be regulated by IFN-γ, because the 
serum levels of IFN-γ are significantly lower after IL-12 and IL-18 neutralization and IL-12 
and IL-18 secreted in macrophages have been shown to induce IFN-γ production. It was 
suggested that macrophages are activated through producing IL-12 p40 which functions as a 
signal to IFN-γ. Neutralization of IL-12 blocks the pathway between macrophage and IFN-γ, 
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resulting in exponential growth of bacteria and a decrease in host survival whereas elevating 
the serum level of IL-12 increases host survival (Kincy-Cain, et al., 1996).  
Apart from direct anti-microbial activities, IFN-γ also takes part in the stimulation of antibody 
production. It induces the increase of IgG2 and lowers the IgG1 levels in cattle (Estes, et al., 
1994). IFN-γ also stimulates T cell proliferation and development (Doucet & Bernard, 1997; 
Theze, 1999). 
Lymphocyte proliferation is a key indicator of the host defence response to invasion of 
pathogens. It is likely that proliferation of T cells in vitro parallels protective immunity in 
vivo. Li et al. (2005) found that the administration of a semi-purified porin-rich vaccine 
induced a proliferative response to the same antigen or LPS in vitro, in sheep. Conversely, 
Doucet and Bernard (1997) found that infection with Salmonella Abortusovis in sheep could 
suppress the lymphoproliferative response in vitro to Concanavalin A (Con A), a non specific 
mitogen. It has been shown that the CD4+ T cell percentages decreased whereas B and MHC-
II+ cell percentages increased in infected sheep (Doucet & Bernard, 1997).  
2.9.2.2 Humoral immunity 
Although Salmonella infections are primarily controlled by cellular immunity, the absence of 
humoral immunity leads to inefficiency in Salmonella clearance as antibodies function by 
binding to the invading microbe and neutralizing it or facilitating uptake opsonisation by 
macrophages and its elimination (Moore, et al., 2003; Pier, et al., 2004). It has been 
demonstrated that antibodies involved in protection against Salmonella infection include 
immunoglobulin M (IgM), IgG and IgA (Husband, 1978; Iankov, et al., 2002; Mukkur, et al., 
1995). By the first week after infection, antibody response can be detected in the sera of 
different species such as chicken (Lee, et al., 1981), sheep (Brennan, et al., 1994), and cattle 
(Lindberg & Robertsson, 1983). IgM is the first isotype elicted among the different isotypes 
of anti-Salmonella antibodies, followed by IgG and IgA (Hassan, et al., 1991). 
Immunoglobulin M (IgM), which accounts for 5-10% of the total serum immunoglobulin, is 
structurally a pentamer. In vivo, IgM was ten times more effective than IgG in promoting 
removal of S. Typhimurium from blood after intravenous infection and a thousand times more 
effective than IgG in promoting killing of the bacteria after intraperitoneal challenge (Saxen, 
1984). Furthermore IgM can amplify the immune response by functions as a powerful 
activator of the complement system.  
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Immunoglobulin G (IgG) is the most abundant class in serum and constitutes approximately 
80% of the total serum immunoglobulin. It protects the body against Salmonella by 
agglutination and immobilization, complement activation (classical pathway), opsonisation 
for phagocytosis and neutralization of their toxin (Paul, 1993). It has been shown that serum 
levels of antibody IgG were linked to host protection against infection with Salmonella in 
many species such as mice, sheep (Bernard, et al., 2002), chickens (Iotova, 1982) and cattle 
(Yokoyama, et al., 1998). 
Immunoglobulin A (IgA) is produced by many species. IgA antibody which constitutes only a 
small proportion (10-15%) of the total immunoglobulin in serum is more predominant in 
external secretions such as breast milk, saliva, tears, and mucus of the bronchial, 
genitourinary and digestive tracts. Secretory IgA (S-IgA), constitutes > 80% of all antibodies 
produced in the mucosa-associated tissues of human and mice, inhibits bacterial adherence, 
neutralizes toxin moieties, mediates protection against infection through antibody-dependent 
cellular cytotoxicity, initiates bactericidal action by iron-sequestering compounds and serves 
as a possible opsonin for mucosal phagocytes (Funakoshi, et al., 1982; Kilian, et al., 1988; 
Tagliabue, et al., 1983). For example, Michetti et al. (1992) demonstrated that the monoclonal 
S-IgA, directed against a surface epitope of S. Typhimurium, could prevent systemic disease 
caused by invasive enteric pathogen.  
2.10 Validity of in vitro culture methods 
Abortion due to S. Brandenburg is one of the most important problems in ovine reproduction 
and breeding in regions of New Zealand (Boxall, et al., 1999). The pathogenesis of abortion 
events are difficult to study in vivo, because of surgical inaccessibility and associated high 
experimental costs. Cell culture provides a low cost model for studying the mechanism of 
abortion caused by S. Brandenburg in vitro. Cells can be infected with S. Brandenburg and the 
infective characteristics of the bacteria in various cell lines can be compared. Similar methods 
have been used to investigate the virulence and host specificities of other Salmonella serovars 
such as Dublin (Pullinger, et al., 2007), Gallinarum (Paulin, et al., 2002) and Choleraesuis 
(Paulin, et al., 2007) in different hosts including cattle, chicken and pigs. In preliminary 
experiments with S. Brandenburg, there appears to be good correlation between invasion 
characteristics in vitro (primary sheep in intestinal cells or immortalised human cell lines) and 
in vivo (ovine ligated ileal loops) experiments (Brandt, et al., 2008). 
In summary, infections due to S. Brandenburg remain a serious problem for New Zealand 
sheep industry, although partial protection can be provided by changes in farm management 
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and vaccination. Understanding the infection characteristics (adhesion, invasion and 
replication) of S. Brandenburg in sheep may lead to improved methods of disease control. 
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     Chapter 3 
Materials and Methods 
All experimental procedures concerning the handling of pathogens were approved by the 
Lincoln University Institutional Bio-safety Committee. 
3.1 Sample collection and experimental design 
Epithelial cells were isolated from the oviduct and ileum of recently slaughtered two-year-old 
(two-tooth) non-pregnant ewes or two-year-old non-pregnant cows. A variety of methods 
were compared in order to optimise cell yield and viability. Adhesion to, invasion of, and 
replication within, ex vivo and in vitro cultured oviduct epithelial cells (OECs) and intestinal 
epthelial cells (IECs) by S. Brandenburg and S. Typhimurium isolates, were quantified by 
means of infection assays (Watson, 1995). This assay was designed as 4 grouped experiments 
based on the hypotheses outlined on p14.  
In experiment 1, different profile 14 isolates of S. Brandenburg derived from sheep foetus, 
cattle foetus and human blood (3684, 3062 and 4468, respectively) or a non-profile 14 isolate 
of S. Brandenburg from pet food (4527), were added into 24 h or 7 day old cell cultures 
derived from sheep oviduct. Three independent assays measured adhesion, invasion and 
replication at 1, 2, and 24 h respectively (Table 3.1).  
In experiment 2, 24 h-old or 7 day-old cell cultures from sheep oviduct were infected with 
either the epidemic S. Brandenburg isolate (3684) or S. Typhimurium isolate (1979), adhesion, 
invasion and replication were compared (Table 3.1). 
In experiment 3, S. Brandenburg isolate (3684) was added to 24 h-old or 7 day-old cell 
cultures either from bovine or ovine oviduct and adhesion, invasion and replication were 
compared (Table 3.1). 
In experiment 4, S. Brandenburg isolate (3684) was added to 7 day-old cell cultures derived 
from either ovine small intestine or ovine oviduct and bacterial adhesion, invasion and 
replication were compared (Table 3.1). 
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Table 3.1 Experimental design. 
 Ex vivo (24 h-old cell culture) In vitro (7 day-old cell culture) 
Experiment 1 
(repeat × 3) 
OOEC 
3684 
OOEC 
3684 
3062 3062 
4468 4468 
4527 4527 
Experiment 2 
(repeat × 3) 
OOEC 
3684 
OOEC 
3684 
1979 1979 
Experiment 3 
(repeat × 3) 
OOEC 
3684 
OOEC 
3684 
BOEC BOEC 
Experiment 4 
(repeat × 3) 
In vitro (7 day-old cell culture) 
OIEC 
3684 
OOEC 
OOEC: Ovine Oviduct Epithelial Cell. 
BOEC: Bovine Oviduct Epithelial Cell. 
OIEC: Ovine Intestinal Epithelial Cell. 
3684
1
: S. Brandenburg isolated from sheep. 
3062
1
: S. Brandenburg isolated from cattle. 
4468
1
: S. Brandenburg isolated from human. 
4527
2
: S. Brandenburg isolated from pet food. 
1979: S. Typhimurium isolated from sheep. 
1
 PFGE genotype profile 14. 
2
 PFGE genotype non-profile 14. 
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3.2 Oviduct epithelium primary culture from sheep and cattle  
A primary cell culture was established by adding the cells lining the oviduct or 
gastrointestinal tract to growth medium. This involved 3 stages: (1) acquisition of the tissue 
sample and isolation of the cells; (2) mechanical or enzymatical disaggregation of the cells; (3) 
culture after seeding into the tissue culture flasks or plates (Freshney, 2005). All equipment 
and solutions used in the subsequent procedure were sterile. 
3.2.1 Isolation of epithelial cells from ovine or bovine oviduct  
Ewe or cow uteri, obtained from a local abattoir, were transported on ice to the laboratory. 
Once in the laboratory, the oviducts were excised from the reproductive tract, sterilized 
externally with 70% ethanol, and the excess connective tissue was trimmed off. After 
trimming, the cells from the inner lining of the oviduct were dislodged into the lumen of the 
oviduct by lightly pressing a clean microscope slide over the exterior surface of the oviduct, 
directed from the isthmus to the ampulla (Figure 3.1). A blunt 18 g needle was inserted into 
the utero-tubal junction (UTJ) and the epithelial cells were flushed out with about 2-5 ml 
Dulbecco PBS (GIBCO) at 37
o
C and added to 10 ml 37
o
C Dulbecco PBS in a 50 ml 
centrifuge tube (Way, 2006). The tube was inverted to suspend cells and left for 10 min to 
allow the cells to settle to the bottom of the tube, and the supernatant was aspirated. If many 
cells remained suspended in Dulbecco PBS, the above process was repeated two to three 
times, and the resultant cells were resuspended gently in 8 ml D-MEM (GIBCO). All the 
procedures were carried out at room temperature. 
3.2.2 Disaggregation of epithelial cells from ovine or bovine oviduct  
For the 24 h cultures, newly isolated epithelial cell clumps in 8 ml D-EMEM were directly 
placed in a 25 cm
2
 NUNC tissue culture flask. To the cells was added 2 ml of 2000 units/ml 
collagenase (Sigma) and 100 µl of 0.06% (w/v) DNase I (Sigma) followed by incubation for 
3-5 h at 37
o
C, with 5% CO2. The cells were then centrifuged at 800 rpm for 10 min and the 
supernatant was discarded. The cell pellet was resuspended in Dulbecco PBS and re-
centrifuged in order to wash off the collagenase and DNase I in the medium. 
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Figure 3.1 (1) Rinsed and trimmed ovine oviduct. (2) Microscope slide pulls along the 
exterior surface of the oviduct toward the infundibulum (right). (3) 
Epithelial cells are flushed into warm, sterile Dulbecco PBS solution. 
The cell wash–centrifugation step was repeated twice and the cell pellet then was suspended 
in 2.5 ml of trypsin-EDTA that contained 2.5 mg/ml trypsin and 0.38 mg/ml Na EDTA 
(GIBCO), followed by 20-30 min of incubation. After disaggregation with the above 
combination of collagenase, DNase I and trypsin-EDTA, most cells were individual. Any 
small undigested cell clumps were disaggregated mechanically using a 1 ml pipette. The 
disaggregated oviduct epithelial cells (OECs) in trypsin-EDTA were diluted with D-MEM 
complete growth medium (supplemented with 10% or 20% FBS). A variety of other 
combinations to effect disaggregation (enzyme type, concentration, incubation time and 
mechanical) were also trialled before this procedure was decided on (Table 3.2). For the 7 
day-old cell cultures, newly isolated cell clumps were immediately transferred into complete 
growth medium and cultured for 7 days at 37
o
C with 5% CO2. After 7 days, the cell 
monolayers were washed with Dulbecco PBS and detached by the addition of 2.5 ml of 
typsin-EDTA for 20-30 min at 37
o
C incubated with 5% CO2. The detached cells were then 
diluted in D-MEM containing 10% or 20% FBS and the viability was assessed after adding 
0.4% (w/v) trypan blue and viewed by light microscopy. 
1
2
3
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Table 3.2 Enzyme combinations tested for disaggregation of OECs. 
Enzymes Time 
DNase I  
(0.6 mg/ml) 
Collagenase  
(400 units/ml) 
Trypsin-EDTA  
(2.5 mg/ml) 
Incubation1  
(37
o
C) 
Incubation2  
(37
o
C) 
 
  
3 h 
 
 
 
 
3 h 
 
  
 30 min 
 
 
 
 3 h 30 min 
 
  3 h 30 min 
 
 
3 h 
 
  3 h 30 min 
3.2.3 Seeding the oviductal cells onto the culture plates 
For the 24 h-old cell cultures, the disaggregated cells were seeded in 24-well poly-l-lysine 
(Sigma) pre-coated culture plates. The recommended working concentration of poly-l-lysine 
was 0.1 mg/ml and 400 µl was loaded into each well. A gentle swirl was given to the plate to 
ensure coverage. The plates with poly-l-lysine were placed in incubation at 37
o
C with 5% 
CO2 for 3 h. The excess reagent was removed and wells were rinsed twice with sterile water; 
followed by Dulbecco PBS, and then D-MEM containing 10% FBS.  
Then, 1 ml cell culture medium containing 5.0-5.2 log10 OECs were placed in each of the 
coated wells and incubated for 20-22 h at 37
o
C with 5% CO2 and maximum humidity. 
For the 7 day-old cell cultures, 1 ml of trypsin-EDTA disaggregated cells at 5.0-5.2 log10 per 
ml were sown in 24-well culture plates (without coating with poly-l-lysine) and cultured for 
12-15 h at 37
o
C with 5% CO2 and maximum humidity. 
3.3 Small intestinal epithelium primary culture from sheep  
3.3.1 Isolation of epithelial cells from ovine small intestine (ileum) 
The method to isolate intestinal epithelial cells (IECs) is derived from that of Evans et al. 
(1992). Epithelial cells were isolated from the distal ileum of slaughtered sheep collected at a 
local abattoir. Approximately 15-20 cm of ileum was placed in RPMI 1640 containing 10% 
(v/v) FBS, 100 µg of streptomycin/ml, 100 U of penicillin/ml, and 2.5 µg of amphotericin 
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B/ml (GIBCO) and then transported on ice to the laboratory. The ileum was then cut into 2 
cm × 2 cm sections. The sections were placed in Hanks balanced salt solution (Bio-Whittaker) 
without Ca
2+ 
or Mg
2+ 
containing 0.1 mM EDTA (BDH) and 0.1 mM dithiothreitol (BDH) and 
incubated at 37°C for 10 min with vigorous shaking (Figure 3.2). The supernatant was then 
removed and the tissue was chopped finely and placed in RPMI 1640 containing 0.05% (w/v) 
collagenase (Sigma) and incubated at 37°C for 15-20 min with vigorous shaking. After this 
procedure, the supernatant consisting of intestinal crypts and single cells was removed with a 
Pasteur pipette, pelleted by centrifugation at 1000 × g for 5 min, and resuspended in D-MEM 
medium containing 10% (v/v) FBS and kept on ice. Fresh collagenase solution was added to 
the biopsy tissue repeatedly two to three times until no more cells could be isolated. The 
pellet was gently resuspended in 10 ml D-MEM plus 10% (v/v) FBS, 0.5 ng/ml of epidermal 
growth factor (EGF) (Sigma), 8 µg/ml of insulin (Sigma), 10 µg/ml of gentamycin (GIBCO), 
50 µg/ml of hydrocortisone (Sigma), 100 µg/ml of streptomycin, 100 U/ml of penicillin 
(GIBCO), and 2.5 µg/ml of amphotericin B (GIBCO) (Hashim, et al., 2004). 
3.3.2 Seeding the IECs onto the culture plates 
The IEC attachment rates can be improved by coating the surface with the attachment factor 
collagen Type I (BD). Collagen Type I was diluted to 300 μg/ml in Dulbecco PBS and 650 µl 
of the working collagen solution was added into each well of the 24-well plates, followed by 
incubation at 37°C with 5% CO2 and maximum humidity for 3 h. After 3 h of incubation, the 
plate covers were removed and the plates were placed in a sterile hood overnight to dry the 
collagen at room temperature. The wells were washed twice with sterile water, and the 
washing was repeated using Dulbecco PBS and D-MEM. Plates were air dried overnight and 
stored at 4°C.  
One ml of the D-MEM containing approximately 5.0-5.2 IECs /ml were added onto the 
collagen-coated plate and cultured for 7 days, at 37
o
C with 5% CO2 and maximum humidity. 
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Figure 3.2 (1) Section of distal ileum (15-20 cm). (2) Washing of ileum (2 × 2 cm
2
). (3) 
Fine dicing of ileum. (4) Incubation with 0.1 mM EDTA and DTT in 
RPMI 1640 medium with 0.05% collagenase. 
3.4 Characterisation of oviduct and small intestinal epithelial cells  
3.4.1 Cell viability and yield examination of cultured cells 
The morphology of newly isolated epithelial cells from sheep and cattle oviduct and ileum 
were examined by light microscopy after 1 h, 24 h or 7 days of culture. The viability and 
number of disaggregated cells were evaluated on a haemocytometer, after staining in trypan 
blue (GIBCO); 20 µl of cell homogenate was diluted in the equal volume of 0.4% (w/v) 
trypan blue and then counted. 
3.4.2 Haematoxylin and Eosin (H&E) staining of cultured OECs  
Staining with haematoxylin and eosin (H&E) was carried out as per Walter (1995). The OECs 
that had been cultured for 24 h or 7 days on poly-l-lysine pre-coated cover slips, were fixed 
using 4% formaldehyde for 30 min. Cells were then stained with 2-5 ml of Harris 
haematoxylin (BDH) and incubated for 30 min at room temperature. After 30 min incubation, 
the haematoxylin solution was washed off with sterile water and cells were incubated in 2-5 
21
3 4
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ml of eosin for another 30 min at room temperature. Cells then were rinsed with Dulbecco 
PBS, mounted in 100% glycerol and examined by light microscopy.  
3.4.3 Giemsa staining of cultured IECs 
Giemsa staining is specific for the phosphate groups of DNA and attaches itself to regions of 
DNA where there are high amounts of adenine-thymine bonding. IECs that had been cultured 
for 7 days on collagen Type I pre-coated cover slips were fixed with 4% formaldehyde for 30 
min. The cell monolayer was incubated at room temperature in freshly prepared Giemsa 
(Sigma) stain for 1 h. The cell monolayer was then rinsed in 0.5% (w/v) aqueous acetic acid 
for 30 min, followed by Dulbecco PBS, mounted in 100% glycerol and examined by light 
microscopy. 
3.4.4 Immunohistochemical characterization of cultured cells  
Indirect immunohistochemical staining of cytokeratin was performed as per Tiemann et al. 
(2001) using a monoclonal antibody to cytokeratin 8 and 18 (Sigma), that is, specific for 
epithelial cells. The cells were fixed with 4% formaldehyde in Dulbecco PBS for 30 min, 
permeabilized with 1% (v/v) Triton X-100 in Dulbecco PBS for 30 min, blocked with 0.5% 
(w/v) bovine serum albumin (BSA) for another 30 min and then incubated with the anti-PAN 
cytokeratin 8 and 18 primary antibody at 10 µg/ml in 0.5% (w/v) BSA, for 12 h at 4
o
C. The 
monolayer was rinsed with Dulbecco PBS 3 times, incubated with 10 µg/ml sheep anti-mouse 
IgG secondary antibody coupled to FITC (Sigma) in 0.5% (w/v) BSA for another 12 h at 4
o
C, 
mounted in 100% glycerol and fluorescence was viewed by microscopy (Leica) at 400 nm. 
3.5 Optimisation of infection assays 
3.5.1 Growth characteristics of Salmonella cultures 
In order to assess the growth characteristics of the Salmonella isolates in Luria-Bertani (LB) 
broth and determine the exponential growth phase, 1.4 ml of pre-cultured (12-15 h at 25
o
C) 
bacteria (isolates 3062, 3684, 4468, 4527 and 1979) was added into 36 ml of Luria-Bertani 
(LB) broth. The LB broth containing bacteria was then incubated in a 37
o
C water bath. 
Culture absorbance was measured (OD600) at 0, 2, 4, 6, 8, 10 or 12 h. As each time point, a 
mean of 3 absorbances was calculated and growth curves were generated. 
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3.5.2 Efficacy of gentamycin 
To determine the ability of gentamycin to inactivate extracellular Salmonella isolates, 100 
μg/ml of gentamycin (GIBCO) was added to D-MEM nutrient medium without antibiotics. 
Overnight cultures of bacteria were added to the medium and incubated for 2 h at 37°C in 5% 
CO2. Samples of 200 μl were taken immediately after the addition of gentamycin and at 30 
min intervals and culture on LB agar plates that were incubated at 37°C overnight and 
Salmonella colony-forming units (CFUs) were quantified. 
3.5.3 Lytic buffer viability assay 
An assay was performed to determine whether Salmonella could survive exposure to sodium 
deoxycholate. Salmonella isolates were grown overnight at 37
o
C in broth culture and 200 μl 
aliquots were taken and centrifuged at 10,000 rpm for 10 min. The bacterial pellet was then 
resuspended in 200 μl of lytic buffer (0.1% sodium deoxycholoate in Dulbecco‘s PBS). 
Samples in triplicate were taken after 10 and 30 min and independently counted with a 10-
fold serial dilution. Bacterial viability was determined on LB agar after overnight incubation 
at 37°C. 
3.6 Salmonella infection assays 
3.6.1 Epithelial cell culture preparation 
The culture methods followed as per Galan and Curtiss (1989). Cells were inoculated in a 24 
well plate at approximately 5.0-5.2 log 10 
 
cells per ml in D-MEM containing 10% (v/v) FBS 
and 1% penicillin/streptomycin (Watson et al., 1995). The plates were incubated for 24 h at 
37
o
C after which the monolayer was washed once with unsupplemented media and 1 h later 
the bacteria were added.  
3.6.2 Bacterial strains and growth conditions 
S. Brandenburg strains isolated during 1996-2006 from sheep, cattle, human and pet food and 
a S. Typhimurium strain isolated from sheep in 2010 were obtained from the ESR Enteric 
Reference Laboratory (Table 3.3).  
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Table 3.3 Bacteria strains used in adhesion, invasion and replication assays. 
Strain NZRM Accession No. Source Host Species 
S. Brandenburg 
3062 Foetus Cattle 
3684 Foetus Sheep 
4468 Foetus/Blood Human 
4527 Pet food Cattle 
S. Typhimurium 1979 Faeces Sheep 
For each assay, a vial of bacterial cells was thawed and cultured on LB agar plates (Sigma) 
overnight at 37°C. For liquid culture, a scraping of a colony was taken from the culture plate 
and transferred to 5 ml of LB broth (Sigma), followed by overnight incubation at 25
o
C with 
vigorous shaking at 150 rpm (Figure 3.3). 
For inoculum preparation, the OD (optical density) of the Salmonella cultures in LB broth 
was measured for adequacy and 200 µl was diluted in 5 ml of fresh LB and incubated with 
shaking at 37
o
C for a further 2 h. The resultant OD was expected to be between 0.6 and 0.8, 
the Salmonella culture was diluted down to an OD of 0.3 and 15 to 30 µl of the Salmonella 
culture was added to 15 ml unsupplemented, pre-warmed D-MEM to give a final bacterial 
concentration of 6.0-6.5 log10 CFUs/ml. 
3.6.3 Enumeration of bacteria 
Bacterial counts were performed after 10-fold serial dilutions by plating out culture onto LB 
agar and assessing after overnight incubation at 37
o
C. The number of bacteria were calculated 
using a modification of the method by Miles et al. (1938). Each serial dilution was assessed 
and a count was undertaken when the number of organisms on the agar plate ranged from 10 
to 100 CFUs. Salmonella recovered in D-MEM without cells were termed ‗media control‘, 
those recovered before the addition of gentamycin were termed ‗adhesion‘, those recovered 
after the gentamycin treatment ‗invasion‘, and those recovered after a further 24 h incubation 
with the gentamycin treatment ‗replication‘ (Figure 3.3).  
 
47 
 
 
Figure 3.3 Flow chart of Salmonella infection assays. 
3.6.4 Media control  
The ability of bacteria to replicate over 1 h was measured by adding Salmonella inoculum into 
the wells without cells. This equated to the number of bacteria ‗available‘ for adhesion. The 
bacteria in the D-MEM were counted as CFUs on LB agar after incubation at 37
o
C for 12-15 
h.  
3.6.5 Adhesion assay 
Oviduct epithelial cells having been cultured for 24 h (ex vivo) or 7 day (in vivo) were washed 
with 1 ml Dulbecco PBS to remove antibiotics before infection with bacteria. In triple wells, 
cells were infected with 1 ml of Salmonella inoculum, which equated to 6.0-6.5 log10 
CFUs/ml bacteria, giving a multiplicity of infection (MOI) of 1:15-20, incubated at 37
o
C for 1 
Isolated mammalian cells
24 h-old,
1  105 cells/ml,
Poly-l-lysine coated 24 well plates
(OECs)
7 day-old
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(OECs and IECs)
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Quantification the dilution when 
the number of organisms on the 
agar plate ranged from 10 to 100 
CFUs
Add 1  106 Salmonella per ml
1 h incubation, PBS wash
Addition of gentamicin,
1 h incubation, PBS wash
Lysis in sodium deoxycholate
Incubation on LB agar
Quantification the dilution when 
the number of organisms on the 
agar plate ranged from 10 to 100 
CFUs
Add 1 106 Salmonella per ml
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Quantification the dilution when 
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h, and washed to remove the un-adhered bacteria (Figure 3.3). Thereafter, 1 ml of lytic buffer 
in Dulbecco PBS was added to each well, and aspirated 5 times. Bacteria in the lytic buffer 
were quantified on LB agar plates after incubation at 37°C for 12-15 h. 
3.6.6 Invasion assay 
The invasion assay was performed separately; one ml of Salmonella inoculum was added to 
each well of a 24-well plate, in triplicate, for each isolate. After 1 h of incubation, the 
monolayers were washed once with Dulbecco PBS and incubated for a further 1 h in un-
supplemented medium containing 100 µg/ml gentamycin (Figure 3.3). This method 
differentiates bacteria that can invade the host cells and those which do not invade. 
Gentamycin added to the cultures does not penetrate eukarytic cells and therefore can not kill 
the bacteria that are already internalized. The Salmonella associated with the monolayers after 
the 1 h incubation with gentamycin were recovered by lysis of the cultured cells with 1 ml of 
Dulbecco PBS containing lytic buffer. Bacteria in the lytic buffer were quantified on LB agar 
plates after incubation at 37°C for 12-15 h. 
3.6.7 Replication assay 
The replication assay was carried out separately to test the replicating abilities of Salmonella. 
One ml of Salmonella inoculum was added to each well of a 24-well plate, in triplicate, for 
each isolate. After 1 h of incubation, the monolayers were washed once with Dulbecco PBS 
and incubated for a further 23 h in un-supplemented D-MEM containing 100 µg/ml of 
gentamycin (Figure 3.3). One ml of 0.1% sodium deoxycholate in Dulbecco PBS was then 
added to each well to release the intracellular bacteria. Bacteria in the sodium deoxycholate 
were quantified on LB agar plates after incubation at 37°C for 12-15 h. 
3.7 Statistical analysis 
The adhesive, invasive and replicative characteristics of the different Salmonella isolates 
when mixed with the different cell types were assessed statistically. Three samples of each 
dilution were tested, and counted in triplicate. Each adhesion, invasion and replication assay 
was independently carried out in 3 separate preparations of OECs/IECs. The viable-count data 
were analysed using parametric analysis (Student two-sample t-test) to assess mean 
differences between source of cells (species and organ) and Salmonella isolate.  
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The variances of the observations in each group were not equal and the two sample sizes were 
not equal hence the raw data was logarithmically transformed for normalization. GenStat (12
th
 
Edition, UK) and Sigmaplot (11.0, USA) was used for statistical analysis and plotting of data, 
respectively. P-values of difference between two groups of observations were obtained by 
referring the calculated value of the test statistic to the t-distribution table. For the adhesion, 
invasion and replication assays a P<0.01 was regarded as significant.  
  
50 
 
     Chapter 4 
Results 
4.1 Oviduct epithelial cell (OEC) cultures 
4.1.1 Cell morphology, yield and viability 
Following isolation, observation by light microscopy showed that bovine and ovine epithelial 
cells were contained in aggregates with vigorously beating cilia on any remaining aggregate 
surfaces (Figure 4.1).  
 
Figure 4.1 Aggregates of OOECs in Dulbecco PBS following isolation. 
The yield of isolated OECs from sheep and cattle ranged from 7.4-7.74 log10 cells and 7.65-
7.90 log10
 
cells per oviduct respectively. In both species, trypan blue staining was positive in 
the majority of singular cells and those cells on the periphery of the cell clumps, while those 
cells on the inside of the cell clumps, which made up the vast majority of the total cells, were 
all viable at 1 h after isolation (Figure 4.2a). 
In order to disaggregate the OECs for the ex vivo assay, newly isolated epithelial cells were 
treated with a combination of collagenase, DNase I and Trypisn-EDTA for 3 h. Several kinds 
of enzymatic combinations were trialled before the optimal procedure was decided on (Table 
4.1). As indicated in Table 4.1, trypsin-EDTA was used as a starting point, and was combined 
200 µm
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with additional proteases to improve disaggregation. The majority of the combinations did not 
separate cell clumps efficiently. More than 90% of the cells were disaggregated with the 
combination of collagenase, DNase I and trypsin-EDTA, followed by mechanical pipetting.  
Table 4.1 Enzyme combinations and proportion of singular viable cells. 
Enzymes 
Mechanical 
pipetting 
% (singular viable cells) 
Trypsin-EDTA Yes 20%-50% 
Trypsin-EDTA + DNase I Yes 50%-70% 
DNase I Yes 20%-30% 
Collagenase Yes 50%-70% 
Collagenase + Trypsin-EDTA Yes 50%-70% 
Collagenase + DNase I Yes 70%-80% 
Collagenase +DNase I + trypsin-EDTA Yes >90% 
After 24 h culture in plates coated with poly-lysine, approximately 80% of the disaggregated 
OECs adhered to the bottom of each well. Cells remained singular with the original 
morphology and polarity (Figure 4.3a). With H&E staining, the shape of cell was spherical 
and cilia were still observed on the cell surfaces (Figure 4.4a). 
For the in vitro assays, the initial OEC cell suspensions contained ciliated and nonciliated 
cells but by 24 h after seeding, free floating epithelial cells had formed vesicles with cilia on 
their external surface. After 48 h (for sheep) or 72 h (for cattle), some cells were adhered to 
the bottom of the flasks and began to form a small monolayer. Others were reassociated into 
aggregates with numerous ciliated cells at the periphery. These reassociated cell clusters 
exhibited rapid motility in the culture medium. When the culture medium was first changed 
on the 3
th
-4
th
 day, the monolayer had extended across approximately 60% of the bottom of the 
wells. The ciliated activity was still observed on clumps of cells or on the top of some 
monolayers. By the 7
th
 day of culture, the cells had reached complete confluency (Figure 
4.3b). With H&E staining, two cell populations were observed: a population of large flat and 
polygonal cells containing some vacuoles surrounded by a second population of smaller cells. 
Most of the cellular cytoplasm was occupied by a large ovoid nucleus (Figure 4.4b). 
Percentage of ovine cell viability tested by the exclusion of trypan blue was 87 ± 4.2% 
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(sheep) and 93 ± 2.9% (cattle) for the 24 h culture and 90 ± 2.3% (sheep) and 89 ± 2.7% 
(cattle) for the in vitro assay (Figure 4.2b). 
4.1.2 Purity of the OEC cultures 
The epithelial nature of these cells was confirmed by immunohistochemical analysis using 
monoclonal antibodies specific to the cytokeratins 8 and 18. In the order of 50% of the 24 h-
old (Figure 4.5) and more than 95 % of the 7 day-old cells stained positive with these anti-
cytokeratin antibodies (Figure 4.6) - typical of non-stratified epithelia. After 7 days of culture, 
the OOECs appeared to be considerably smaller than the BOECs. All nuclei of the 7 day-old 
cells were surrounded by a meshwork of stained filaments (Figure 4.6), while for 24 h-old 
cells; this meshwork could not be clearly observed (Figure 4.5). The control assay using only 
secondary antibody conjugated with fluorescence but with no primary antibody showed no 
signal. 
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Figure 4.2 Evaluation of OOECs viability at 1 h after isolation (a) or on day 7 (b). 
Non-viable cells (arrows) are stained blue. 
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Figure 4.3 Phase-contrast micrograph of enzymatically dissociated OOECs in D-
MEM (a) and confluent layer of cultured OOECs, after 7 days of culture 
(b) . where cilia on the surface are absent. 
  
a
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Figure 4.4 Micrograph of enzymatically dissociated OOECs (a) - cilia (arrows) can be 
observed on the apical membrane. Confluent monolayer of 7 day-old 
OOECs (b). H&E staining of both preparations. 
  
a
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Figure 4.5 Micrograph of 24 h-old OECs following immunostaining for cytokeratin 8, 
18 from (a) sheep and (c) cattle. Figure (b) and (d) are primary antibody 
blank controls. 
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Figure 4.6 Micrograph of 7 day-old OECs following immunostaining for cytokeratin 
8, 18 in (a) ovine and (c) bovine cells. Note the filaments (white arrows) in 
the cytoplasma. Figures (b) and (d) are primary antibody blank controls. 
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4.2 Intestinal epithelial cell (IEC) cultures  
4.2.1 Cell morphology, yield and viability 
Following isolation, observations using light microscopy showed most epithelial cells were 
singular and suspended in the culture medium. The yield of harvested IECs from sheep ranged 
from 8.0-8.4 log10 cells in each 2 cm × 2 cm ileum section. Trypan blue showed cell viability 
was more than 90% (Figure 4.7).  
 
Figure 4.7 OIEC viability after 1 h isolation where non-viable cells (arrows) are 
stained blue. 
For the in vitro assay, the isolated OIECs were cultured in D-MEM supplemented with 10% 
(v/v) FBS, 50 ng of EGF/ml, 8 µg of insulin/ml, 10 µg of gentamycin/ml, 50 µg of 
hydrocortisone/ ml, 100 µg of streptomycin/ml, 100 U of penicillin/ml, and 2.5 µg of 
amphotericin B/ml at 37
o
C, with 5% CO2. The cultures generally grew in 24-well plates 
coated with collagen; cells began to attach and spread over the surface after 72 h. When the 
culture media was first changed on the 3
th
-4
th
 day, approximately 40% of the bottom of the 
wells was covered by cells. Small cobblestone colonies extended and ultimately coalesced, 
forming a confluent monolayer by the 7
th
 day (Figure 4.8a). With Giemsa staining two cell 
populations were observed. One population was spherical cells, while the other population 
was made up of large flat and polygonal cells (Figure 4.8b). 
100 µm
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4.2.2 Purity of the IEC cultures 
As with the OECs, cell purity was characterized by immunohistochemical analysis using 
antibodies against cytokeratins 8 and 18. Approximately 50%-60% of cells stained positive. 
The cells that stained positive were the spherical population, while the flat and polygonal cells 
were negative (Figure 4.8c). The control assay using only the secondary antibody conjugated 
with fluorescence showed no signal. 
 
 
 
 
a
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Figure 4.8 Phase-contrast micrograph of confluent layer of cultured OIECs after 7 
days of culture (a). Confluent monolayer of 7 day-old OIECs with Giemsa 
staining (b). Immunostaining for cytokeratin 8, 18 (c). Figure (d) is 
primary antibody blank control. 
4.3 Optimisation of infection assays  
4.3.1 Growth characteristics of Salmonella cultures 
Following overnight (12-15 h) incubation at 25
o
C, the S. Brandenburg strains were further 
grown in LB broth for 2, 4, 6, 8, 10, or 12 h, at 37
o
C, in order to determine their growth 
curves. In general, the growth of Salmonella isolates was most rapid in the first 2 h with a 
growth plateau occurring after 4 h for 3684, 3062, 4468 and 4527 and 6 h for 1979 (Figure 
4.9). The concentration of all these Salmonella isolates after 2 h were higher than 6.0 log10 
CFUs per ml (OD=0.300), sufficient for the infectivity assays. 
  
200 µm
c d
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Figure 4.9 Growth curves of S. Brandenburg isolates (3602, 3684, 4468, and 4527) 
and S. Typhimurium isolate (1979) with SD. 
4.3.2 Efficacy of gentamycin 
Gentamycin (GIBCO) was tested for its ability to inhibit the growth of S. Brandenburg and S. 
Typhimurium isolates in cell culture media. All of the S. Brandenburg and S. Typhimurium 
strains were immediately inactivated after exposure to gentamycin in vitro and thereafter 
throughout the gentamycin protection assay. 
4.3.3 Lytic buffer viability assay 
The ability of sodium deoxycholate to lyse the OECs and its potential toxicity to Salmonella 
was tested. Treatment with 0.1% Sodium deoxycholate (Sigma) resulted in complete lysis of 
the OECs within 5 min as assessed by light microscopy. To test the potential toxicity of the 
lytic buffers, various Salmonella isolates were suspended in plain D-MEM medium or sodium 
deoxycholate for 30 min. Following lytic treatment to the S. Brandenburg and Typhimurium 
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isolates with 0.1% sodium deoxycholate there were similar recoveries to the D-MEM control 
with sodium deoxycholate (Table 4.2). Therefore, 0.1% sodium deoxycholate was chosen as a 
cell lytic buffer for the gentamycin protection assay. 
Table 4.2 Quantification of Salmonella viability after incubation in lytic buffer (log10 
[CFUs/ml]). 
Isolates Lytic Buffer 
Bacterial Recovery (mean ± SD) 
10 min 30 min 
3684 
Media control 12.7 (± 0.03) 12.8 (± 0.01) 
0.1% Sodium 
deoxycholate 
12.8 (± 0.04) 12.8 (± 0.03) 
3062 
Media control 12.9 (± 0.02) 12.9 (± 0.02) 
0.1% Sodium 
deoxycholate 
12.9 (± 0.01) 12.9 (± 0.04) 
4468 
Media control 12.9 (± 0.02) 12.9 (± 0.01) 
0.1% Sodium 
deoxycholate 
12.9 (± 0.04) 12.9 (± 0.03) 
4527 
Media control 12.9 ( ± 0.02) 12.9 (± 0.01) 
0.1% Sodium 
deoxycholate 
12.9 ( ± 0.02) 12.9 (± 0.02) 
1979 
Media control 12.7 (± 0.01) 12.7 (± 0.02) 
0.1% Sodium 
deoxycholate 
12.8 (± 0.01) 12.8 (± 0.01) 
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4.4 Salmonella infection assays 
4.4.1 Salmonella infections in 24 h-old OOEC cultures  
The infection characteristics of S. Brandenburg and S. Typhimurium were compared in 
OOECs cultured in a 24-well plate at approximately 5.0 log 10
 
cells per ml, in D-MEM 
containing 10% (v/v) FBS. To the cell cultures were added S. Brandenburg isolates (3062, 
3684, 4468 and 4527) or S. Typhimurium isolate (1979) at a multiplicity of infection (MOI) 
of 1:20-40 (Appendix B.1, Figure 4.10). The infection process was divided into three parts; 
adhesion, invasion and replication, according to the stage of the bacterial infection. 
4.4.1.1 Media control  
An estimate of the proliferative ability of bacteria in growth media without the presence of 
cells was made following the addition of S. Brandenburg (3684, 3062, 4468, and 4527) and S. 
Typhimurium (1979). Generally there was a little variation among the Salmonella isolates in 
the media control after 1 h incubation. The total number of Salmonella organisms varied from 
6.88 (isolate 3062) log10 CFUs per ml to 6.78 (isolate 4527) log10 CFUs per ml. For each 
isolate, the variance was between 0.001 and 0.008 log10 CFUs (Table 4.3). 
4.4.1.2 Adhesion assay  
After 1 h of incubation, the percentage of Salmonella that adhered to 24 h-old OOECs ranged 
from 0.2% (isolate 1979) to 1% (isolate 3684). That is, the number of adhered bacteria 
following washing of the cells divided by the numerical value of the same isolate after culture 
in media for 1 h. Isolate 3684 adhered at approximately 4.80 log10 CFUs per ml, followed in 
descending order by isolates 4468, 3062, 4527 and 1979. The variance of each isolate ranged 
from 0.007 (isolate 3062) to 0.100 (isolate 1979) log10CFUs per ml (Table 4.3). 
4.4.1.3 Invasion assay  
As a separate assay, following 1 h incubation, 100 µg of gentamycin was added to the cell 
cultures and incubation proceeded for another 1 h to kill the extracellular organisms. As 
described in Figure 4.10, the number of bacteria invading the OOECs varied from 3.67 log10 
CFUs per ml (isolate 3684) to 3.18 log10 CFUs per ml (isolate 4527). The percentage of 
bacteria that were intracellular divided by those originally adhered uptake ranged from 27% 
(isolate 1979) to 7% (isolate 3684). The variance of the triplicates of each isolate ranged from 
0.002 (isolate 3684) to 0.172 (isolate 1979) log10 CFUs per ml (Table 4.3).  
64 
 
4.4.1.4 Replication assay  
The bacteria that had penetrated into cells with the addition of 100 µg of gentamycin were 
further incubated for 23 h to allow them to replicate. After 24 h incubation, the replication 
level of Salmonella isolates fluctuated between 5.02 log10 CFUs per ml (isolate 3684) and 4.0 
log10 CFUs per ml (isolate 4527). The multiplication rate collected from replication number 
divided by invasion number varied from 20 to 22 fold (isolates 3062, 3684 and 4468) to 6 or 7 
fold (isolates 1979, 4527). The variance of triplicates of each isolate ranged from 0.198 
(isolate 3684) to 0.394 (4468) log10 CFUs per ml (Table 4.3).  
Table 4.3 Means and variances of media control, adhesion, invasion, and replication 
of Salmonella in 24 h-old OOEC cultures (log10 [CFUs/ml]). 
OOECs, 24 h, 10% FBS 
Isolates Media control Adhesion Invasion Replication 
3062 6.88 (0.001) 4.56 (0.007) 3.60 (0.016) 4.91 (0.271) 
3684 6.80 (0.005) 4.80 (0.076) 3.67 (0.002) 5.02 (0.198) 
4468 6.80 (0.005) 4.62 (0.008) 3.64 (0.020) 4.98 (0.394) 
4527 6.78 (0.005) 4.30 (0.035) 3.18 (0.029) 4.00 (0.284) 
1979 6.82 (0.008) 4.21 (0.100) 3.64 (0.172) 4.42 (0.386) 
 
  
65 
 
 
Figure 4.10 Media control, adhesion, invasion and replication of S. Brandenburg and 
S. Typhimurium isolates in 24 h-old OOEC cultures, with SEM bars (in 
triplicate). 
4.4.1.5 Student t-test comparisons of adhesion, invasion and replication  
Adhesion, invasion and replication abilities of the Salmonella isolates over 24 h in the 
OOECs were based on the means of the triple measurements of 3 samples for 3 separate 
experiments, and were compared among each other using the Student t-test (Table 4.4, 
Appendix C.1 and D.1). 
There were no significant differences between the S. Brandenburg isolates 3062, 3684, and 
4468. The adhesion of S. Brandenburg isolates (3062, 3684 and 4468) was higher than S. 
Typhimurium isolate 1979 (P<0.01), and isolates 3684, and 4468 adhered more than isolate 
4527 (P<0.01). 
The results of the invasion assay indicated that S. Brandenburg isolate 4527 invaded 
significantly less than S. Brandenburg and S. Typhimurium isolates 3062, 3684, 4468, 1979 
(P<0.01), but there was no difference between the S. Brandenburg isolates 3062, 3684, and 
4468 and S. Typhimurium isolate 1979. 
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The replication of S. Brandenburg isolate 4527 was significantly lower than isolates 3062, 
3684, 4468 and 1979 (P<0.01). The replication of S. Brandenburg isolates 3062, 3684, 4468 
was statistically higher than S. Typhimurium isolate 1979 (P<0.01). There were no significant 
differences between S. Brandenburg isolates 3062, 3684, 4468. 
Table 4.4 Student t-test values for adhesion, invasion and replication of Salmonella 
in 24 h-old OOEC cultures. 
Isolates Adhesion Invasion Replication 
3062 vs 3684 -1.77 -0.56 -0.83 
3062 vs 4468 -0.42 -0.34 -0.50 
3062 vs 4527 1.97 3.14* 6.92* 
3062 vs 1979 2.65* -0.31 3.77* 
3684 vs 4468 1.35 0.22 0.33 
3684 vs 4527 3.74* 3.70* 7.75* 
3684 vs 1979 4.42* 0.25 4.60* 
4468 vs 4527 2.39* 3.48* 7.42* 
4468 vs 1979 3.08* 0.03 4.27* 
4527 vs 1979 0.68 -3.45* -3.15* 
* represents significant differences between isolates at 99% confidence interval 
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4.4.2 S. Brandenburg infection in 24 h-old OOEC and BOEC cultures  
This assay was focused on the host specificity of S. Brandenburg; OOECs and BOECs were 
cultured for 24 h in 24-well plates at approximately 5.0 log 10
 
cells per ml in complete D-
MEM, containing 20% FBS. To the cell cultures was added the epidemic S. Brandenburg 
isolate 3684 at 1:20-40 MOI (Appendix B.2, Figure 4.11).  
4.4.2.1 Media control 
When Salmonella isolate (3684) was cultured in D-MEM without cells, a two to four fold 
multiplication of bacteria usually occurred (Appendix B2), which gave a final concentration 
of 6.66 log10 CFUs per ml for the ovine cell assay and 6.80 log10 CFUs per ml for the bovine 
cell assay. The variance in ovine cells was 0.002 log10 CFUs per ml as compared to 0.009 
log10 CFUs per ml in bovine cells (Table 4.5). 
4.4.2.2 Adhesion assay 
After 1 h of incubation, 4.76 log10 CFUs per ml of bacteria adhered to the OOECs as 
compared to 4.51 log10 CFUs per ml in the BOECs cultures. The proportion of bacterial 
adhesion, that is, the number of adhered bacteria following washing of cells divided by the 
numerical value after culture in media for 1 h, was 1.3% (ovine cells) compared to 0.5% 
(bovine cells). The variance in ovine cells was 0.005 log10 CFUs per ml as compared to 0.035 
log10 CFUs per ml in bovine cells (Table 4.5). 
4.4.2.3 Invasion assay 
With the addition of gentamycin, 3.39 log10 CFU per ml of bacteria invaded OOECs as 
compared to 3.60 log10 CFUs per ml of bacteria that were internalized in the BOECs. That is, 
4% of bacteria invaded OOECs, as compared to 12% in the BOEC cultures. The variance in 
ovine cells was 0.01 log10 CFUs per ml as compared to 0.081 log10 CFUs per ml in bovine 
cells (Table 4.5). 
4.4.2.4 Replication assay 
After 24 h incubation, 5.14 log10 CFUs per ml of bacteria had replicated in OOECs as 
compared to 4.27 log10 CFUs per ml in BOEC. That is, replication frequencies of 56 fold in 
OOECs versus 5 fold in BOECs. The variance in ovine cells was 0.012 log10 CFUs per ml as 
compared to 0.182 log10 CFUs per ml in bovine cells (Table 4.5). 
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Table 4.5 Means and variances of media control, adhesion, invasion, and replication 
of S. Brandenburg in 24 h-old OOEC and BOEC cultures (log10 
[CFUs/ml]). 
S. Brandenburg isolate 3684, 20% FBS 
Stage Sheep Cattle 
Media control 6.66 (0.002) 6.8 (0.009) 
Adhesion 4.76 (0.005) 4.51 (0.035) 
Invasion 3.39 (0.01 ) 3.60 (0.081) 
Replication 5.14 (0.012) 4.27 (0.182) 
 
Figure 4.11 Media control, adhesion, invasion and replication of S. Brandenburg in 24 
h-old OOEC and BOEC cultures, with SEM bars (in triplicate). 
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4.4.2.5 Student t-test comparison of adhesion, invasion and replication  
Adhesion, invasion and replication abilities of the Salmonella isolate 3684 over 24 h in the 
OOEC and BOECs were based on the means of the triple measurements of 3 samples for 3 
separate experiments, and were compared among each other using the Student t-test (Table 
4.6, Appendix C.2 and D.2). 
Table 4.6 Student t-test values for adhesion, invasion and replication of S. 
Brandenburg in 24 h-old OOEC and BOEC cultures.  
Species Adhesion Invasion Replication 
Sheep vs Cattle 4.56* -3.96* 15.91* 
* represents significant differences between species at 99% confidence interval 
The results indicate that S. Brandenburg isolate 3684 adhered to and replicated within OOECs 
more than BOECs (P<0.01). However, invasion of the bacteria in ovine cells was less than in 
bovine cells (P<0.01). 
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4.4.3 Salmonella infection in 7 day-old OOEC cultures  
As with ex vivo assays, cells were cultured in a 24-well plate at approximately 5.0 log 10
 
cells 
per ml in D-MEM containing 10% (v/v) FBS. To the cell cultures were added S. Brandenburg 
isolates (3062, 3684, 4468 and 4527) or S. Typhimurium isolate (1979) at a MOI of 1:20-40 
(Appendix B.3, Figure 4.12). 
4.4.3.1 Media control  
An estimate of the proliferative ability of bacteria in growth media without the presence of 
cells was made following the addition of S. Brandenburg (3684, 3062, 4468, and 4527) and S. 
Typhimurium (1979). The number of Salmonella isolates organisms 1 h incubation in media 
varied from 6.56 (isolate 4468) log10 CFUs per ml to 7.18 (isolate 4527) log10 CFUs per ml. 
For each isolate, the variance was between 0.029 and 0.115 log10 CFUs per ml (Table 4.7). 
4.4.3.2 Adhesion assay  
After 1 h of incubation, the percentage of Salmonella that adhered to 7 day-old OOECs 
ranged from 2% (isolate 4527) to 13% (isolate 1979). That is, the number of adhered bacteria 
following the washing of cells divided by the numerical value of the same isolate after culture 
in media for 1h. Isolate 1979 adhered at approximately 6.04 log10 CFUs per ml, which was 
the highest amount followed in descending order by isolates 3684, 3062, 4468 and 4527. The 
variance of each isolate ranged from 0.014 (isolate 4527) to 0.259 (isolate 1979) log10 CFUs 
per ml (Table 4.7). 
4.4.3.3 Invasion assay  
As a separate assay, following 1 h incubation, 100 µg of gentamycin was added to the cell 
cultures and incubation proceeded for another 1 h to kill the extracellular organisms. As 
described in Figure 4.12, the number of bacteria invading the OOECs varied from 5.21 log10 
CFUs per ml (isolate 1979) to 5.13 log10 CFUs per ml (isolate 3062 and 3684). The 
percentage of bacteria that were intracellular divided by those originally adhered ranged from 
30% (isolate 3062) to 13% (isolate 4527). The variance of the triplicates of each isolate 
ranged from 0.005 (isolate 4527) to 0.12 (isolate 4468) log10 CFUs per ml (Table 4.7).  
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4.4.3.4 Replication assay  
The bacteria that had penetrated into cells with the addition of 100 µg of gentamycin were 
further incubated for 23 h to allow them to replicate. After 24 h incubation, the replication 
level of Salmonella isolates fluctuated between 6.13 log10 CFUs per ml (isolate 1979) and 
5.73 log10 CFUs per ml (isolate 3062). The number of replicated bacteria divided by the 
invasion number varied from 4 fold (isolates 3684, 3062) to 18 fold (isolate 4527). The 
variance of triplicates of each isolate ranged from 0.005 (isolate 4527) to 0.183 (3684) log10 
CFUs per ml (Table 4.7).  
Table 4.7 Means and variances of media control, adhesion, invasion, and replication 
of Salmonella in 7 day-old OOEC cultures (log10 [CFUs/ml]). 
OOECs, 7 day, 10% FBS 
Isolates Media control Adhesion Invasion Replication 
3062 6.68 (0.029) 5.66 (0.032) 5.13 (0.078) 5.73 (0.122) 
3684 6.70 (0.060) 5.75 (0.050) 5.13 (0.086) 5.74 (0.183) 
4468 6.56 (0.069) 5.49 (0.072) 4.94 (0.120) 6.16 (0.100) 
4527 7.18 (0.077) 5.45 (0.014) 4.56 (0.005) 5.82 (0.005) 
1979 6.94 (0.115) 6.04 (0.259) 5.21 (0.025) 6.13 (0.010) 
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Figure 4.12 Media control, adhesion, invasion and replication of S. Brandenburg and 
S. Typhimurium in 7 day-old OOEC culture, with SEM bars (in 
triplicate). 
4.4.3.5 Student t-test comparisons of adhesion, invasion and replication  
Adhesion, invasion and replication abilities of the Salmonella isolates in the 7 day-old 
OOECs were based on the means of the triple measurements of 3 samples for 3 separate 
experiments which were compared among each other using the Student t-test (Table 4.8, 
Appendix C.3 and D.3). 
The adhesion of S. Typhimurium isolate 1979 was greater than S. Brandenburg isolates 3062, 
3684, 4468, and 4527 (P<0.01).  
The invasion of S. Brandenburg isolate 3062, 3684, 4468 and S. Typhimurium isolate 1979 
was significantly higher than the S. Brandenburg isolate 4527 (P<0.01). S. Typhimurium 
isolate 1979 invaded more than S. Brandenburg isolate 4468 (P<0.01). 
The replication of 4468 and 1979 were significantly more than 3062, 3684 and 1979 
(P<0.01). However, there were no significant differences between isolate 3062, 3684, and 
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4527 and S. Brandenburg isolate 4468 replicated at a similar rate to S. Typhimurium isolate 
1979. 
Table 4.8 Student t-test values for adhesion, invasion and replication of Salmonella 
in 7 day-old OOEC cultures. 
Isolates Adhesion Invasion Replication 
3062 vs 3684 -0.81 -0.01 -0.08 
3062 vs 4468 1.5 1.7 -3.86* 
3062 vs 4527 1.85 5.15* -0.8 
3062 vs 1979 -3.52* -0.76 -3.59* 
3684 vs 4468 2.31 1.71 -3.78* 
3684 vs 4527 2.65* 5.15* -0.72 
3684 vs 1979 -2.71* -0.75 -3.51* 
4468 vs 4527 0.35 3.45* 3.06* 
4468 vs 1979 -5.02* -2.46* 0.27 
4527 vs 1979 -5.36* -5.91* -2.79* 
* represents significant differences between isolates at 99% confidence interval 
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4.4.4 S. Brandenburg infections in 7 day-old OOEC and BOEC cultures  
For the ex vivo assays, OOEC and BOECs were cultured for 24 h in 24-well plates at 
approximately 5.0 log 10
 
cells per ml in complete D-MEM containing 20% FBS. To the cell 
cultures was added the epidemic S. Brandenburg isolate 3684 at 1:20-40 MOI (Appendix B.4, 
Figure 4.13).  
4.4.4.1 Media control 
When Salmonella isolate (3684) was cultured in D-MEM without cells, a two to four fold 
multiplication of bacteria usually occurred (Appendix B4), which gave a final concentration 
of 6.67 log10 CFUs per ml for ovine cell assay and 7.02 log10 CFUs per ml for bovine cell 
assay. The variance in ovine cells was 0.126 log10 CFUs per ml as compared to 0.06 log10 
CFUs per ml in bovine cells (Table 4.9). 
4.4.4.2 Adhesion assay 
After 1 h of incubation, approximately 5.59 log10 CFUs per ml of bacteria adhered to the 
OOECs as compared to 5.64 log10 CFUs per ml in BOECs cultures. The proportion of 
bacterial adhesion, that is, the number of adhered bacteria following washing of cells divided 
by the numerical value after culture in media for 1 h, was 7% (ovine cells) compared to 4% 
(bovine cells). The variance in ovine cells was 0.007 log10 CFUs per ml as compared to 0.015 
log10 CFUs per ml in bovine cells (Table 4.9). 
4.4.4.3 Invasion assay 
With the addition of gentamycin, 5.44 log10 CFU per ml of bacteria invaded OOECs as 
compared to 5.47 log10 CFUs per ml of bacteria that were internalized in the BOECs. That is, 
71% of bacteria invaded OOECs, as compared to 68% in the BOEC cultures. The variance in 
ovine cells was 0.005 log10 CFUs per ml as compared to 0.021 log10 CFUs per ml in bovine 
cells (Table 4.9). 
4.4.4.4 Replication assay 
After 24 h incubation, 6.13 log10 CFUs per ml of bacteria were replicated in OOECs as 
compared to 5.48 log10 CFUs per ml in BOECs. That was a replication frequency of 5 fold in 
OOECs versus 1 fold in BOECs. The variance in ovine cells was 0.269 log10 CFUs per ml as 
compared to 0.028 log10 CFUs per ml in bovine cells (Table 4.9). 
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Table 4.9 Mean and variances of media control, adhesion, invasion and replication 
of S. Brandenburg in 7 day-old OOEC and BOEC cultures (log10 
[CFUs/ml]). 
S. Brandenburg isolate 3684, 20% FBS 
Stage Sheep Cattle 
Media control 6.77 (0.126) 7.02 (0.060) 
Adhesion 5.59 (0.007) 5.64 (0.015) 
Invasion 5.44 (0.005) 5.47 (0.021) 
Replication 6.13 (0.269) 5.48 (0.028) 
 
 
Figure 4.13 Media control, adhesion, invasion and replication of S. Brandenburg in 7 
day-old OOEC and BOEC cultures, with SEM bars (in triplicates). 
  
Media Control Adhesion Invasion Replication
L
o
g
1
0
 (
C
F
U
 p
er
 m
l-
1
)
0
2
4
6
8
Sheep 
Cattle 
76 
 
4.4.4.5 Student t-test comparison of adhesion, invasion and replication  
Adhesion, invasion and replication abilities of the Salmonella isolate 3684 in the 7 day-old 
OOECs and BOECs were based on the means of the triple measurements of 3 samples for 3 
separate experiments and were compared between each other using the Student t-test (Table 
4.10, Appendix C.4 and D.4). 
Table 4.10 Student t-test values for adhesion, invasion and replication of S. 
Brandenburg in 7 day-old OOEC and BOEC cultures. 
Species Adhesion Invasion Replication 
Sheep vs Cattle -1.02 -0.61 11.68* 
* represents significant differences between species at 99% confidence interval 
The result of t-test (Replication) showed that replication of S. Brandenburg was significantly 
more in OOEC, as compared to BOEC cultures (P<0.01). However, there were no significant 
differences between sheep and cattle for adhesion and invasion. 
  
77 
 
4.4.5 Salmonella infections in 7 day-old OOEC and OIEC cultures 
This assay was to test the tissue tropism of S. Brandenburg. OIECs and OOECs were 
routinely cultured in a 24-well plate at approximately 5.0 log 10
 
cells per ml in D-MEM 
containing 10% FBS. To the cell cultures was added S. Brandenburg isolate 3684 at an 
approximate MOI of 1:20-40 (Appendix B.5, Figure.4.14). As with the previous assays, the 
process of infection was divided into adhesion, invasion and replication.  
4.4.5.1 Media control 
When Salmonella isolate (3684) was cultured in D-MEM without cells, a two to four fold 
multiplication of bacteria usually occurred (Appendix B5), which gave a final concentration 
of 6.78 log10 CFUs per ml for OIECs assay and 6.70 log10 CFUs per ml for OOECs assay. The 
variance in OIECs was 0.005 log10 CFUs per ml as compared to 0.06 log10 CFUs per ml in 
OOECs (Table 4.11). 
4.4.5.2 Adhesion assay 
After 1 h of incubation, approximately 5.63 log10 CFUs per ml of bacteria adhered to the 
OIECs as compared to 5.75 log10 CFUs per ml in OOECs cultures. The proportion of bacterial 
adhesion, that is the number of adhered bacteria following washing of cells divided by the 
numerical value after culture in media for 1 h, was 7% (OIEC cultures) compared to 11% 
(OOEC cultures). The variance in OIEC cultures was 0.002 log10 CFUs per ml as compared to 
0.050 log10 CFUs per ml in OOECs (Table 4.11). 
4.4.5.3 Invasion assay 
With the addition of gentamycin, 4.34 log10 CFU per ml of bacteria invaded OIECs as 
compared to 5.13 log10 CFUs per ml of bacteria that were internalized in the OOECs. That 
was 5% of bacteria invaded OIECs, as compared to 24% in the OOEC cultures. The variance 
in OIEC cultures was 0.013 log10 CFUs per ml as compared to 0.087 log10 CFUs per ml in 
OOECs cultures (Table 4.11). 
4.4.5.4 Replication assay 
After 24 h incubation, 5.43 log10 CFUs per ml of bacteria were replicated in OIECs as 
compared to 5.74 log10 CFUs per ml in OOECs. That was a replication frequency of 12 fold 
78 
 
in OIECs versus 4 fold in OOECs. The variance in OIECs was 0.018 log10 CFUs per ml as 
compared to 0.183 log10 CFUs per ml in OOECs (Table 4.11). 
Table 4.11 Means and variances of media control, adhesion, invasion and replication 
of S. Brandenburg in 7 day-old OIEC and OOEC cultures (log10 
[CFUs/ml]). 
S. Brandenburg isolate 3684, 10% FBS 
Stage OIEC  OOEC 
Media control 6.78 (0.005) 6.7 (0.060) 
Adhesion 5.63 (0.002) 5.75 (0.050) 
Invasion 4.34 (0.013) 5.13 (0.087) 
Replication 5.43 (0.018) 5.74 (0.183) 
 
 
Figure 4.14 Adhesion, invasion and replication of S. Brandenburg in 7 day-old OIEC 
and OOEC cultures, with SEM bars (in triplicate). 
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4.4.5.5 Student t-test comparison of adhesion, invasion and replication  
Adhesion, invasion and replication abilities of the Salmonella isolate 3684 in the 7 day-old 
OIECs and OOECs were based on the means of the triple measurements of 3 samples for 3 
separate experiments, and were compared among each other using the Student t-test (Table 
4.12, Appendix C.5 and D.5). 
Table 4.12 Student t-test values for adhesion, invasion and replication of S. 
Brandenburg in 7 day-old OIEC and OOEC cultures. 
Cell lines Adhesion Invasion Replication 
OIEC vs OOEC -1.90- -12.93* -5.03* 
* represents significant differences between cell lines at 99% confidence interval 
The results of t-test (Invasion and Replication) showed that invasion and replication of the 
isolate 3684 in OOECs were greater than in OIECs (P<0.01). However, there was no 
significant difference between OIECs and OOECs for adhesion.  
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     Chapter 5 
Discussion and conclusion 
5.1 Infection assays 
The virulence strategy common to Salmonella is to adhere, invade and multiply in the host 
cells. Establishment of these processes relies on virulence factors which are responsible for 
the pathogencity of Salmonella (Baumler, et al., 2000) and defence mechanisms exhibited by 
the host animal (Wray & Wray, 2000). Yet to date, little work has been done to investigate 
these differences in infective ability, host specificity and tissue tropism.  
5.1.1 Infection differences between S. Brandenburg isolates in OOEC cultures 
Since 1996, S. Brandenburg isolates have been typed by pulsed field gel electophoresis 
(PFGE). Those isolates showing the same DNA fingerprint resulting from digestion with the 
restriction endonuclease XbaI as an epidemic isolate were assigned as profile 14 (Clark, et al., 
2004). These isolates that share the same PFGE genotype are considered to originate from the 
same strain. In our ex vivo assays, there was no difference among the isolates 3062, 3684, and 
4468 for adhesion, invasion and replication (Table 4.4). Similarly, in the in vitro assays, there 
was no difference among isolates 3062, 3684, 4468 for adhesion, and invasion, although 
isolate 4468 replicated more than isolates 3062 and 3684 (Table 4.8). Hence, those isolates 
with a similar profile 14 genotype are associated with a similar phenotype for adhesion, 
invasion and replication. 
In contrast, isolate 4527 that had a DNA banding pattern of non-profile 14 strains (Baker, et 
al., 2007; Wong, et al., 2007; Wright, et al., 1998) invaded less than profile 14 isolates 3062, 
3684 and 4468 in ex vivo and in vitro cultures of OOECs.  
Salmonella-induced invasion involves many genes and a rather intimate interaction between 
the bacteria and the host cell (Ochman & Groisman, 1996). Bacteria-induced invasion is 
initiated by ligand-receptor interactions on the host cell surface and injected effectors into the 
host cell, inducing cytoskeletal rearrangements that result in passive entry of bacteria (Patel & 
Galan, 2005). The invasion process involves a series of actin cytoskeletal changes induced by 
the translocated effectors. In mammalian cells, major rearrangements of the actin cytoskeleton 
upon receptor stimulation or other stimulation are controlled by specific small guanosine 
triphosphate (GTP)–binding proteins, CDC42 and Rac1 (Guiney & Lesnick, 2004). At least 
81 
 
five effectors contribute to Salmonella-induced invasion. These proteins activate GTP-binding 
protein-dependent signalling cascades (CDC-42 and Rac1) to induce cytoskeleton 
rearrangements (Hardt, et al., 1998; Zhou, et al., 2001), mediate the recovery of cytoskeletal 
architecture of the host cells once internalization occurs (Fu & Galan, 1999) and regulate 
bundling of actin filaments and nucleation of actin polymers (Hayward & Koronaki, 1999). 
Salmonella strains deficient in any of those effectors may exhibit a varied cellular invasion 
phenotype (Zhou, et al., 2001). Decreased invasion potential was described with another non-
profile 14 S. Brandenburg isolate (NZRM 96-0105) as compared to isolate 3684 in both in 
vitro intestinal cell culture (7 days) and in vivo gut loop preparation (Brandt, et al., 2008). 
Together with our results it suggests that invasion of epithelial cells from at least 2 sites 
(intestine and oviduct) is impaired in the non-profile 14 phenotype.  
In addition, in the ex vivo (but not the in vitro) culture, replication of the profile 14 isolates 
was higher than the non-profile 14 isolate. The reason for this discrepancy could relate to the 
different populations of cells or changed functionally in those cells cultured over 7 days. 
Following invasion, Salmonella survive within a modified phagosome known as the 
Salmonella containing vacuole (SCV) (Ibarra & Steele-Mortimer, 2009). Late stage SCV 
modifications (6 to 8 hrs after infection) include the formation of tubular membrane 
extensions known as Salmonella-induced filaments (Sifs) in which intracellular replication in 
some cell types can be found (Drecktrah, et al., 2008). About 16 T3SS-2 effectors contribute 
to numerous intracellular events, including SCV maturation, Sif formation, bacterial 
replication and the systemic spread of bacteria. The intracellular pathogen residing in a 
vacuole triggers the Sif formation within which replication then occurs (Drecktrah, et al., 
2008; Ramsden, et al., 2007). Mutation of the gene of coding for those effectors may vary the 
replication phenotype of Salmonella isolates.  
Although, there is no direct evidence to suggest that non-profile 14 isolates are less virulent 
than the profile 14 isolates, all S. Brandenburg isolates recorded from the recent epidemic 
from the South Island of New Zealand were typed as profile 14 (Clark, et al., 2004). The 
decreased invasion and replication (at least in ex vivo) of non-profile 14 isolate 4527 is 
consistent with the results of Brandt et al. (2008), and leads to the conclusion that virulence of 
S. Brandenburg is correlated with bacterial invasion and replication potential because invasion 
of ileal loops in vivo has been associated with virulence. Potential gene sequences that may be 
associated with pathogenicity between S. Brandenburg profile 14 (3684) and non-profile 14 
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(96-0105) isolates have been predicted based on a genomic subtraction hybridisation 
technique (Brandt, et al., 2008).  
5.1.2 Infection differences between S. Brandenburg and S. Typhimurium in OOEC 
cultures 
In the ex vivo assays, most of the S. Brandenburg isolates (3062, 3684, 4468-all profile 14) 
adhered to and replicated within OOECs more than S. Typhimurium isolate 1979 (Table 4.4). 
On the contrary, in the in vitro assay the S. Typhimurium isolate 1979 adhered to and 
replicated within OOECs more than most of the S. Brandenburg isolates (3062, 3684, and 
4527) (Table 4.8). That is, the infection characteristics of Salmonella differed in ex vivo and 
in vitro OOEC cultures. As the cells for the ex vivo assay had been isolated and cultured for 
only 24 h, the morphology, function and polarity were likely to have been better maintained 
compared to the in vitro OOECs, and thus are more likely to reflect the in vivo situation. 
Bacterial adherence is a very critical step for initiating the infection and successful invasion 
and replication is dependent on the direct contact with host cells. Fimbriae are the main 
factors responsible for Salmonella adhesion. Most members of the Salmonella display 
numerous fimbriae on their cell surface that are thought to modulate interaction between 
pathogens and host cells (Brandt, et al., 2008; Wilson, et al., 2000). Genomic analysis reveals 
that 15 operons are found to encode fimbriae (Wagner & Hensel, 2011). The distribution of 
fimbrial operons among Salmonella strains suggests a role for fimbriae in pathogenesis. 
Broadly distributed fimbrial operons may provide general adhesive functions such as for S. 
Typhimurium but fimbriae whose distribution is limited may provide specific functions 
required in virulence for example S. Brandenburg (Edwards, et al., 1999). Further genome or 
proteomic analysis of the studied Salmonella isolate will be necessary to describe any such 
differences. Whatever the molecular reasons for the difference, we propose that enhanced 
adhesion to and replication within cells from the reproductive tract may be the reason that the 
profile 14 S. Brandenburg strains are more pathogenic for pregnant sheep reproductive tract 
compared to S. Typhimurium. 
5.1.3 Infection differences between S. Brandenburg in OOEC and BOEC cultures  
The replicating ability of S. Brandenburg isolate 3684 within OOECs was better than in 
BOECs for both ex vivo and in vitro assays (Table 4.6 and 4.10). This suggests that there is a 
degree of host specificity at the cellular level that may account for the more severe disease 
seen in sheep compared to cattle. In New Zealand over the past fifteen years, infections due to 
S. Brandenburg have been found in sheep, and cattle. The fact is that S. Brandenburg in cattle 
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has only occurred from areas where disease has been prevalent in sheep. This can occur from 
contaminated water ways and probably back-backed gulls. Furthermore, the disease 
prevalence in cattle is relatively lower than sheep, especially in the reproductive tract (Clarke 
& Tomlinson, 2004). In this study, the increased replicative ability of S. Brandenburg in 
OOEC compared to BOEC may account for the virulence of the disease in sheep. As faecal 
shedding of carrier animals and oral ingestion are important in maintaining S. Brandenburg in 
sheep flocks, one alternative possibility is that S. Brandenburg might be maintained in 
numbers high enough to infect sheep but too low to infect cattle that are co-grazing or in close 
proximity (Baskerville & Dow, 1973; Gray, et al., 1995). That is the induction of infectious 
diarrhea in cattle is insufficient to maintain S. Brandenburg on a long-term basis within the 
bovine population. The similar case has also been found in other serotypes. For example, S. 
Dublin is able to establish a carrier state in adult animals, which acts as a continual source of 
infection for cattle. If S. Brandenburg is unable to establish its own carriage in cattle this may 
limit its maintenance within the bovine population (Paulin, et al., 2002).  
In addition, Salmonella-induced filaments (Sifs) are the replication site of bacteria inside the 
cells and are very essential for Salmonella replication. Although all of the mechanisms of 
Salmonella replication remained unknown, Sifs and Sif formation is only produced in 50-80% 
of infected cells and in certain animal species (Beuzon, et al., 2000; Boucrot, et al., 2003). 
This may be another reason that S. Brandenburg replicated greater in sheep than cattle. 
5.1.4 Infection differences between S. Brandenburg in OOEC and OIEC cultures 
In the present study, the S. Brandenburg isolate 3684 adhered to OOECs at a similar level to 
OIECs but invaded and replicated in OOECs more than OIECs (Table 4.12). This should 
enable S. Brandenburg to induce more significant damages to the ovine oviduct and 
surrounding tissues than to intestines, all other factors remaining the same. The cellular or 
biochemical reasons that could explain the differences between the 2 cell types are unknown. 
Infection with serotypes Abortusovis and Brandenberg are similar in that they both cause 
abortion in vivo but the mechanism may be different because the latter invades ovine ileal 
loops greater than Abortusovis (McFarlane & Lantier, unpublished). Moreover, there are 
substantial differences between the pathology of S. Brandenburg and S. Abortusovis 
following field (Mearns, 2007) or experimental (Li, et al., 2005) infections. The former causes 
gastrointestinal pathology and abortion commonly followed by death in the pregnant ewe 
whereas the latter causes few systemic clinical signs aside from abortion (Wray & Wray, 
2000). 
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Paulin et al. (2002) suggested that disease outcomes of S. enteric serotypes in calves are 
associated with the degree of bacterial dissemination from the intestinal lumen to the target 
tissues. This was supported by the findings of Uzzau et al. (2000), in sheep, where S. enterica 
serovars Abortusovis (host restricted), Dublin (host adapted), and Gallinarum (host restricted) 
were recovered in comparable numbers from the intestinal mucosa, but serovar Gallinarum 
was recovered in lower numbers than the other serovars from systemic sites, following oral 
challenge. The pattern of bacterial recovery from systemic sites following intravenous 
inoculation was similar. Note that these experiments were conducted in young animals and 
did not include samples from the reproductive tract. Recently, levels of intestinal invasion 
(ovine ligated ileal loop) with S. Brandenburg have been shown to be at least as high as S. 
Typhimurium in Coopworth (Brandt, et al., 2008) and INRA 401 sheep (McFarlane & Lantier, 
unpublished). Our results indicate that dissemination of S. Brandenburg is not the only 
potential reason for pathology in the reproductive tract. There is an inherent ability of cells in 
the oviduct to encourage a higher rate of invasion and replication of these bacteria. Clearly if 
this finding can be confirmed with in vivo experiments, then it explains many of the features 
relating to the organisms tropism to the reproductive tract.  
Although the infection characteristics of S. Brandenburg in this study can be linked to disease 
outcome and severity using in vitro or ex vivo modelling, this model system cannot represent 
the complex interaction operation within entire animals. Indeed, the validity of cultured cells 
as a model of physiological function in vivo has frequently been criticized. It has been pointed 
out that cells do not express the correct in vivo phenotype due to the altered cell‘s 
microenvironment. The cell-cell and cell-matrix interactions are reduced as the cells lack the 
heterogeneity and three-dimensional architecture present in vivo, and many hormonal and 
nutritional stimuli are absent. This creates an environment that favours the spreading, 
migration and proliferation of unspecialized progenitor cells rather than the highly 
differentiated and functional cells found in vivo (Freshney, 2005).  
Furthermore, a cell culture does not contain components of the immune system such as 
antibodies, phagocytes and cytokines which are playing very critical roles in both host 
protection and host-specificity. These components exert their effects on host-pathogen 
interaction through various intricate biological processes. Typically following Salmonella 
infection, innate immune responses are present. Many host cells produce reactive oxygen 
molecules, largely through the activity of the phagosome NADPH oxidase (Nox2) that is 
counteracted by a Salmonella-produced superoxide dismutase, SodCI, conferring protection 
(Pacello, et al., 2008). In sheep, NRAMP1 (natural resistance-associated macrophage protein 
85 
 
one or Slc11A1), a divalent metal-proton symporter found in macrophages, neutrophils and 
DCs (Nairz, et al., 2009) was shown to inhibit the intestinal dissemination of the serovars 
Brandenburg, Typhimurium and Abortusovis in experiments with ovine ligated loops 
(McFarlane & Lantier, unpublished). In addition, the acquired immune response is critical for 
protection in vivo with both humoral and cell mediated components (Moore, et al., 2003; Pier, 
et al., 2004). Therefore, infecting cultured cells with Salmonella may only partially explain 
the bacterial infecting characteristics, pathogenesis and host specificity. 
5.2 Cell preparation and optimization of infection assays 
In former studies, mechanical disaggregation has been used to separate cell clumps. For 
example, Lasfargues (1973) pressed the dissected tissue through a series of sieves where the 
mesh is gradually reduced in size. Alternatively, the cell aggregate was pushed through a 
syringe graduating from wide to narrow gauge needles (Rottmayer, et al., 2006). By this 
method acceptable cell morphology and polarity remained. However, mechanical 
disaggregation is labour consuming and the separated cells easily re-clump due to cell-cell 
adhesion. Cell-cell adhesion in tissue is mediated by a variety of homotypic, interacting 
glycopeptides. Some of them are calcium-dependent in extracellular matrixes which are 
sensitive to chelating agents such as EDTA. Some exist in the intercellular matrix and 
basement membrane and are protease sensitive and can be digested by enzymes such as 
glycanases (Freshney, 2005). Thus, compared with mechanical disaggregation, using enzymes 
to disaggregate OECs is less labour consuming and fewer re-clumping events occurred, which 
was consistent with our results of optimisation experiments. For the ex vivo assays, newly 
isolated OECs needed to be disaggregated more aggressively. A combination of DNase I, 
collagenase and trypsin-EDTA was used to hydrolyse the DNA released from dead cells, 
chelate the Ca
2+
 in the mucosa or oviduct fluid and digest the collagen contributing to cell-cell 
adhesion on the surface. As multiple enzymatic treatment was more damaging, as detected by 
cell viability estimates, a balance was achieved between cell yield and quality (Reischl, et al., 
1999). 
Serum contains growth factors which promote cell proliferation and adherence factors and 
exhibit antitrypsin activity, all of which promote cell attachment (Bottenstein, et al., 1979). 
The most popular sera in use are bovine calf serum or fetal bovine serum (FBS) for more 
demanding cell lines and cloning (Hyvonen, et al., 1988). The optimal concentration of 
bovine calf serum or fetal bovine serum used in the culture of OECs and IECs was 10%, a 
widely accepted concentration. However, BOECs started to adhere to the flask 1-2 days later 
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than the ovine cells in 10% FBS media and a confluent monolayer was formed after 8-9 days. 
Hence in order to achieve similar cell growth in ovine and bovine comparative OECs for 
infection assays, the concentrations of FBS were increased to 20%. This result is consistent 
with the reports from Ryan (1979). 
Trypan blue does not enter a viable cell but, it does traverse the membrane of a dead cell. 
Hence the exclusion of trypan blue was used as a measure of cell viability (Al-Qubaisi, et al., 
2011). In this study, over 95% of the harvested cells from the oviduct were viable, and those 
that were dead were typically single cells rather than those in aggregates, in agreement with 
Rottmayer et al. (2006). Viability estimates were particularly important for the ex vivo assays, 
where if the percentage of viable cells was too low (<80%) following treatment with the 
various hydrolytic enzymes, the infection assay with Salmonella was not carried out as 
adhesion, invasion and replication characteristics of the Salmonella were likely to be affected 
(Paulin, et al., 2007). 
Cytokeratins (CK) are intermediate filament proteins making up cytoplasmic cytoskeletal 
structures of epithelial cells. They have been used to characterize epithelial cell types since 
they were initially found almost 30 years ago (Karantza, 2011; Moll, 1993). 
Immunocytochemistry is a practical and specific method to determine cell characteristics and 
distinguish between epithelial cells and fibroblast contamination because the monoclonal 
antibody is highly specific for a particular epitope of each of the cell types. In this study, 
monoclonal antibodies to cytokeratin 8 and 18 were used to characterize the cultured cells 
(Abe & Hoshi, 1997; Reischl, et al., 1999; Rottmayer, et al., 2006). In 7 day-old BOECs, the 
keratin filaments form a typical and clear complex network which extends from the surface of 
the nucleus to the cell membrane. This result is consistent with another report (Walter, 1995). 
Unlike BOECs, ovine cells expressed a relatively darker image which may reflect the weaker 
signal from a partly reacting bovine primary antibody to cytokeratin as suggested by Abe and 
Hoshi (1997).  
Multiplicity of infection (MOI) refers to the number of bacteria or virus that is added per cell 
during infection. Typically low MOI is used when multiple cycles of infection are required. 
Kusters et al. (1993) suggest that the number of microorganisms that adhere or invade is 
related to the MOI. When added at equal MOIs, there are no significant differences in 
adhesion and invasion between mid-logarithmic and stationary-phase bacteria. They also 
reported that an incubation time of 30 mins is adequate for adhesion and 2 h for invasion 
when using a MOI ≥ 10, using S. Typhimurium. In this study, the MOI varied from 20-40 
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which ensured that all cells were exposed to bacteria and the infection environment among the 
experiments were consistent.  
In conclusion, in this study S. Brandenburg profile 14 isolates (3062, 3684 and 4468) share 
similar phenotypes in adhesion, invasion and replication all of which are greater than a non-
profile 14 isolate. Secondly, the profile 14 isolates invaded more than S. Typhimurium. 
Thirdly, ovine oviduct cells allow replication of S. Brandenburg to a greater extent than 
bovine cells. Fourthly, S. Brandenburg invades and replicates within ovine oviduct cells more 
readily than ovine intestinal cells. These findings in general support the 4 hypotheses 
proposed and may account for the observation that S. Brandenburg preferentially affects the 
reproductive tract of sheep. 
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     Chapter 6 
Future research 
This thesis reports on a study that was designed to test differential isolate infectivity, host 
specificity and tissue tropism of S. Brandenburg by using ex vivo and in vitro oviduct 
epithelial cells and intestinal epithelial cells from sheep and cattle. The study was undertaken 
to account for field observations of abortion in sheep, in New Zealand with the intention of 
providing an alternative direction for control of this disease. However our studies have 
limitations and further research is recommended for the future.  
Firstly, all the experiments were carried out in ex vivo and in vitro model systems which may 
not thoroughly mimic what happens in vivo. The results from those models cannot represent 
the complex interaction of whole animals. Therefore, an in vivo infection assay is 
recommended as a follow up experiment based on the results from ex vivo and in vitro model 
systems. The ligated ileal loop model has been used successfully in the past to assess 
intestinal infectivity in vivo but a novel method will need to be developed to assess infectivity 
of the reproductive tract. 
Secondly, it is well known that the microclimate (nutritional, immunological) in which the 
Salmonella reside is critical to their survival. Hence the ability to manipulate these factors in 
conjunction with in vivo experiment should be informative. This may mean using animal 
models that have been manipulated to this end, such as genetic (NRAMP1 +/-) or 
immunological (DC +/-) knockouts. Work with the former is in progress. 
Thirdly, former studies have revealed that several genes resident in SPI-1 and SPI-2 are 
responsible for Salmonella virulence which is play important roles in their adhesion, invasion 
and replication. Thus a molecular study on epidemic-strain specific genes should be 
meaningful among S. Brandenburg and other Salmonella serovars with links to phenotypic 
characteristics in vitro or in vivo. 
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     Appendix A 
Sources of material 
Material Supplier Catalog NO. 
24-well plate NUNC 143982 
75 cm2 cell culture flask NUNC 156367 
25 cm2 cell culture flask NUNC 156499 
Amphotericin B  GIBCO 04195780 D  
Anti-mouse IgG-FITC Sigma F0257 
Bovine serum albumin (BSA) Sigma A7906 
Collagen BD 354236 
Collagenase Sigma 17018-029 
Dithiothreitol BDH 441494N 
DNase I  Sigma H5025 
Dulbecco's Modified Eagle Medium (D-MEM) GIBCO 11995-040 
Dulbecco's phosphate-buffered saline (D-PBS) GIBCO 14040-133 
EDTA BDH 100935V 
EGF Sigma G9641 
Foetal bovine serum (FBS)  GIBCO 10091-148  
Formaldehyde AnalaR 10113 
Gentamycin (10mg/ml) GIBCO 15710-072 
Giemsa Sigma G9641 
Hanks balanced salt solution (HBS) GIBCO 14170-112  
Harris haematoxylin BDH 351945s 
Hydrocortisone GIBCO H6909 
Insulin GIBCO 12585-014 
Luria-Bertani broth Sigma L3522 
Monoclonal anti-cytokeratin pan antibody 
produced in mouse Sigma C2562 
Penicillin/streptomycin, (10,000 units) GIBCO 15140-122  
Poly-l-lysine Sigma P2636 
RPMI 1640 GIBCO 23400-021 
Sodium deoxycholate  Sigma  D6750 
Trypan blue GIBCO 15250-061  
Trypsin-EDTA GIBCO 25200-056 
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     Appendix B 
Single Salmonella infection experiments 
B.1 Salmonella infection in 24 h-old OOEC cultures 
B.1.1 Assay (1) 
 
Cell counting: 4.95 log 10 /ml; 15 µL of inoculum in 15mL of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
4527 1 -6 37 42 36 3.70E+09 4.20E+09 3.60E+09
1979 1 -6 44 31 35 4.40E+09 3.10E+09 3.50E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg.(CFU/ml) Avg.log(CFU/ml) Error OD (600nm) MOI (CFU/cell)
4527 9.57 9.62 9.56 3.83E+09 9.58 0.04 0.382 43
1979 9.64 9.49 9.54 3.67E+09 9.56 0.08 0.349 41
Strain Sample Dilution 1 2 3 1 2 3
4527 1 -3 55 56 57 5.50E+06 5.60E+06 5.70E+06
1979 1 -3 53 51 58 5.30E+06 5.10E+06 5.80E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.(CFU/ml) Avg.log(CFU/ml) Error MOI Growth rate
4527 6.74 6.75 6.76 5.60E+06 6.75 0.01 62 1
1979 6.72 6.71 6.76 5.40E+06 6.73 0.03 60 1
Strain Sample Dilution 1 2 3 Average Error
4527 1 neat 0 0 0 0 0
1979 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -1 24 21 20 21666.7 4.34
2 -1 20 19 20 19666.7 4.29
3 -1 26 21 25 24000.0 4.38
1 -1 29 24 22 25000.0 4.40
2 -1 21 17 20 19333.3 4.29
3 -1 22 23 18 21000.0 4.32
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 neat 35 31 26 3066.7 3.49
2 neat 30 27 23 2666.7 3.43
3 neat 20 18 16 1800.0 3.26
1 -1 11 18 14 14333.3 4.16
2 -1 10 17 21 16000.0 4.20
3 -1 23 14 19 18666.7 4.27
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -1 33 48 43 41333.3 4.62
2 -1 40 30 33 34333.3 4.54
3 -1 31 39 42 37333.3 4.57
1 -2 12 13 20 150000.0 5.18
2 -2 15 10 13 126666.7 5.10
3 -2 13 14 17 146666.7 5.17
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
LB
5.15 0.04
0.04
3.39 0.12
1979
LB
Spot Count
4527
4.21 0.06
Replication (24 h)
1979
1979
Invasion (2 h)
4.78
Spot Count
LB
Spot Count
4527
4.34 0.06
0.04
Inocula
Media control (MC)
Gentamicin control (GC)
Adhesion (1 h)
Spot Count CFU/ml
4.34
Spot Count
Log(CFU/ml Count)
Spot Count CFU/ml
Log(CFU/ml Count)
4527
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Cell counting: 4.93 log 10 /ml; 15 µL of inoculum in 15mL of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -5 63 54 55 6.30E+08 5.40E+08 5.50E+08
3062 1 -5 45 50 42 4.50E+08 5.00E+08 4.20E+08
4468 1 -5 63 65 60 6.30E+08 6.50E+08 6.00E+08
LB 1 neat 0 0 0
Strain 1 2 3 Avg.(CFU/ml) Avg.log(CFU/ml) Error OD (600nm) MOI (CFU/cell)
3684 8.80 8.73 8.74 5.73E+08 8.76 0.04 0.331 34
3062 8.65 8.70 8.62 4.57E+08 8.66 0.04 0.32 27
4468 8.80 8.81 8.78 6.27E+08 8.80 0.02 0.285 37
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -3 73 79 75 7.30E+06 7.90E+06 7.50E+06
3062 1 -3 84 76 71 8.40E+06 7.60E+06 7.10E+06
4468 1 -3 48 56 55 4.80E+06 5.60E+06 5.50E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.(CFU/ml) Avg.log(CFU/ml) Error MOI (CFU/cell) Growth rate
3684 6.86 6.90 6.88 7.57E+06 6.88 0.02 89 3
3062 6.92 6.88 6.85 7.70E+06 6.89 0.04 91 3
4468 6.68 6.75 6.74 5.30E+06 6.72 0.04 62 2
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
3062 1 neat 0 0 0 0 0
4468 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -1 49 55 43 49000.0 4.69
2 -1 44 48 40 44000.0 4.64
3 -1 44 43 40 42333.3 4.63
1 -1 33 45 49 42333.3 4.63
2 -1 34 32 38 34666.7 4.54
3 -1 42 44 48 44666.7 4.65
1 -1 52 67 58 59000.0 4.77
2 -1 46 44 57 49000.0 4.69
3 -1 33 30 43 35333.3 4.55
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 neat 42 46 41 4300.0 3.63
2 neat 49 44 47 4666.7 3.67
3 neat 47 54 50 5033.3 3.70
1 neat 42 50 38 4333.3 3.64
2 neat 59 38 55 5066.7 3.70
3 neat 43 42 49 4466.7 3.65
1 neat 54 66 63 6100.0 3.79
2 neat 82 70 72 7466.7 3.87
3 neat 55 49 50 5133.3 3.71
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -2 16 15 15 153333.3 5.19
2 -2 17 23 21 203333.3 5.31
3 -2 15 20 18 176666.7 5.25
1 -2 14 10 11 116666.7 5.07
2 -2 17 28 21 220000.0 5.34
3 -2 41 24 37 340000.0 5.53
1 -2 25 25 22 240000.0 5.38
2 -2 32 28 33 310000.0 5.49
3 -2 47 45 51 476666.7 5.68
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
CFU/ml
Spot Count CFU/ml
4.65 0.03
Log Count
Log(CFU/ml Count)
Inocula
Media control (MC)
Gentamicin control (GC)
Spot Count
Adhesion (1 h)
Spot Count
Spot Count
4468 4.67 0.11
3062 4.61 0.06
3684
3062 3.66 0.04
LB
Spot Count
3684 3.67 0.03
Invasion (2 h)
4468 3.79 0.08
LB
Spot CountReplication (24 h)
3062 5.31 0.23
3684 5.25 0.06
4468 5.52 0.15
LB
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B.1.2 Assay (2) 
 
 
  
Cell counting: 5.08 log 10 /ml; 15 µl of inoculum in 15ml of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
4527 1 -6 37 42 36 3.70E+09 4.20E+09 3.60E+09
1979 1 -6 44 31 35 4.40E+09 3.10E+09 3.50E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg.(CFU/ml) Avg.log(CFU/ml) Error OD (600nm) MOI(CFU/cell)
4527 9.57 9.62 9.56 3.83E+09 9.58 0.04 0.382 32
1979 9.64 9.49 9.54 3.67E+09 9.56 0.08 0.349 31
Strain Sample Dilution 1 2 3 1 2 3
4527 1 -3 76 73 75 7.60E+06 7.30E+06 7.50E+06
1979 1 -3 84 87 86 8.40E+06 8.70E+06 8.60E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.(CFU/ml) Avg.log(CFU/ml) Error MOI Growth rate
4527 6.88 6.86 6.88 7.47E+06 6.87 0.01 63 2
1979 6.92 6.94 6.93 8.57E+06 6.93 0.01 71 2
Strain Sample Dilution 1 2 3 Average Error
4527 1 neat 0 0 0 0 0
1979 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -1 22 31 33 28666.7 4.46
2 -1 27 36 36 33000.0 4.52
3 -1 31 34 37 34000.0 4.53
1 -1 28 27 31 28666.7 4.46
2 -1 28 28 29 28333.3 4.45
3 -1 33 30 41 34666.7 4.54
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 neat 11 10 10 1033.3 3.01
2 neat 13 11 15 1300.0 3.11
3 neat 13 11 12 1200.0 3.08
1 neat 20 20 15 1833.3 3.26
2 neat 21 20 23 2133.3 3.33
3 neat 28 25 36 2966.7 3.47
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -1 10 14 15 13000.0 4.11
2 -1 17 13 11 13666.7 4.14
3 -1 13 13 11 12333.3 4.09
1 -1 24 28 26 26000.0 4.41
2 -1 36 30 26 30666.7 4.49
3 -1 31 26 31 29333.3 4.47
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
1979 4.46
1979 3.35 0.11
LB
Spot Count
4527 4.22 0.02
0.04
LB
Replication (24 h)
LB
Spot Count
4527 3.07 0.05
Invasion (2 h)
0.04
Gentamicin control (GC)
Adhesion (1 h)
4.48 0.05
Spot Count CFU/ml
Log(CFU/ml Count)
Inocula
Media control (MC)
Log(CFU/ml Count
Spot Count
1979
Spot Count CFU/ml
Spot Count
4527 4.50
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Cell counting: 4.95 log 10 /ml; 15 µL of inoculum in 15mL of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 26 22 27 2.60E+09 2.20E+09 2.70E+09
3062 1 -6 22 30 40 2.20E+09 3.00E+09 4.00E+09
4468 1 -6 38 28 20 3.80E+09 2.80E+09 2.00E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/ml Avg.log(CFU/ml) Error OD (600nm) MOI (CFU/cell)
3684 9.41 9.34 9.43 2.50E+09 9.40 0.05 0.354 28
3062 9.34 9.48 9.60 3.07E+09 9.49 0.13 0.284 34
4468 9.58 9.45 9.30 2.87E+09 9.46 0.14 0.349 31
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -3 66 63 62 6.60E+06 6.30E+06 6.20E+06
3062 1 -3 76 73 79 7.60E+06 7.30E+06 7.90E+06
4468 1 -3 74 69 75 7.40E+06 6.90E+06 7.50E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/ml Avg.log(CFU/ml) Error MOI Growth rate
3684 6.82 6.80 6.79 6.37E+06 6.80 0.01 71 3
3062 6.88 6.86 6.90 7.60E+06 6.88 0.02 84 2
4468 6.87 6.84 6.88 7.27E+06 6.86 0.02 81 3
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
3062 1 neat 0 0 0 0 0
4468 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -2 12 16 13 136666.7 5.14
2 -2 18 17 21 186666.7 5.27
3 -2 11 13 14 126666.7 5.10
1 -1 41 42 44 42333.3 4.63
2 -1 45 39 41 41666.7 4.62
3 -1 38 33 40 37000.0 4.57
1 -1 40 43 47 43333.3 4.64
2 -1 42 41 41 41333.3 4.62
3 -1 51 39 43 44333.3 4.65
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 neat 51 57 53 5366.7 3.73
2 neat 50 43 52 4833.3 3.68
3 neat 43 37 40 4000.0 3.60
1 neat 51 40 45 4533.3 3.66
2 neat 49 44 46 4633.3 3.67
3 neat 20 17 22 1966.7 3.29
1 neat 23 31 24 2600.0 3.41
2 neat 31 35 40 3533.3 3.55
3 neat 33 38 31 3400.0 3.53
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -2 27 25 15 223333.3 5.35
2 -2 26 24 36 286666.7 5.46
3 -2 25 27 29 270000.0 5.43
1 -2 13 18 10 136666.7 5.14
2 -2 19 16 14 163333.3 5.21
3 -2 23 20 18 203333.3 5.31
1 -2 22 23 24 230000.0 5.36
2 -2 11 12 18 136666.7 5.14
3 -2 24 23 26 243333.3 5.39
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Inocula
Gentamicin control (GC)
Media control (MC)
4468 5.29
3062 3.54
4468 4.63
Spot Count
Log(CFU/ml Count)
Log(CFU/ml Count)
Spot Count
Spot Count
Spot Count
0.14
LB
LB
Spot Count
3062 5.22 0.09
3684 5.31 0.06
4468 3.50 0.07
3684 3.67 0.06
CFU/ml
Spot Count CFU/ml
Replication (24 h)
Invasion (2 h)
Adhesion (1 h)
0.02
3684 5.17 0.09
LB
3062 4.60 0.03
0.21
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B.1.3 Assay (3) 
 
 
 
 
Cell counting: 4.9 log 10 /ml; 15 µl of inoculum in 15ml of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
4527 1 -6 34 42 26 3.40E+09 4.20E+09 2.60E+09
1979 1 -6 56 63 71 5.60E+09 6.30E+09 7.10E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/ml Avg.log(CFU/ml) Error OD (600nm) MOI(CFU/cell)
4527 9.53 9.62 9.41 3.40E+09 9.53 0.10 0.382 45
1979 9.75 9.80 9.85 6.33E+09 9.80 0.05 0.349 84
Strain Sample Dilution 1 2 3 1 2 3
4527 1 -3 54 55 51 5.40E+06 5.50E+06 5.10E+06
1979 1 -3 68 60 59 6.80E+06 6.00E+06 5.90E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/ml Avg.log(CFU/ml) Error MOI Growth rate
4527 6.73 6.74 6.71 5.33E+06 6.73 0.02 76 2
1979 6.83 6.78 6.77 6.23E+06 6.79 0.03 83 1
Strain Sample Dilution 1 2 3 Average Error
4527 1 neat 0 0 0 0 0
1979 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average
1 -1 17 10 12 13000.0 4.11
2 -1 14 11 13 12666.7 4.10
3 -1 10 11 11 10666.7 4.03
1 -1 12 11 17 13333.3 4.12
2 neat 45 54 52 5033.3 3.70
3 neat 41 43 57 4700.0 3.67
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 neat 12 11 13 1200.0 3.08
2 neat 15 14 10 1300.0 3.11
3 neat 10 12 16 1266.7 3.10
1 neat 28 25 26 2633.3 3.42
2 neat 19 25 23 2233.3 3.35
3 neat 23 25 17 2166.7 3.34
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 neat 18 17 10 1500.0 3.18
2 neat 22 23 20 2166.7 3.34
3 neat 31 30 31 3066.7 3.49
1 neat 44 41 41 4200.0 3.62
2 neat 45 43 40 4266.7 3.63
3 neat 48 51 59 5266.7 3.72
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
1979 3.66
1979 3.37 0.05
LB
Spot Count
4527 3.38 0.16
0.05
LB
Replication (24 h)
LB
Spot Count
4527 3.10 0.02
Invasion (2 h)
0.05
Gentamicin control (GC）
Adhesion (1 h)
3.83 0.25
Spot Count CFU/ml
Log(CFU/ml Count)
Inocula
Media control (MC)
Log(CFU/ml Count
Spot Count
1979
Spot Count CFU/ml
Spot Count
4527 4.08
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Cell counting: 4.93 log 10 /ml; 15 µl of inoculum in 15ml of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 26 22 27 2.60E+09 2.20E+09 2.70E+09
3062 1 -6 22 30 40 2.20E+09 3.00E+09 4.00E+09
4468 1 -6 38 28 20 3.80E+09 2.80E+09 2.00E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/ml Avg.log(CFU/ml) Error OD (600nm) MOI (CFU/cell)
3684 9.41 9.34 9.43 2.50E+09 9.40 0.05 0.354 32
3062 9.34 9.48 9.60 3.07E+09 9.49 0.13 0.284 36
4468 9.58 9.45 9.30 2.87E+09 9.46 0.14 0.349 34
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -3 51 53 57 5.10E+06 5.30E+06 5.70E+06
3062 1 -3 67 83 75 6.70E+06 8.30E+06 7.50E+06
4468 1 -3 71 54 66 7.10E+06 5.40E+06 6.60E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/ml Avg.log(CFU/ml) Error MOI Growth rate
3684 6.71 6.72 6.76 5.37E+06 6.73 0.02 63 2
3062 6.83 6.92 6.88 7.50E+06 6.88 0.05 88 2
4468 6.85 6.73 6.82 6.37E+06 6.80 0.06 75 2
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
3062 1 neat 0 0 0 0 0
4468 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -1 46 42 37 41666.7 4.62
2 -1 34 35 36 35000.0 4.54
3 -1 33 37 41 37000.0 4.57
1 -1 27 23 30 26666.7 4.43
2 -1 30 36 32 32666.7 4.51
3 -1 35 27 33 31666.7 4.50
1 -1 38 30 31 33000.0 4.52
2 -1 49 40 38 42333.3 4.63
3 -1 33 31 42 35333.3 4.55
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 neat 51 57 44 5066.7 3.70
2 neat 46 50 43 4633.3 3.67
3 neat 45 43 48 4533.3 3.66
1 neat 38 39 43 4000.0 3.60
2 neat 41 44 45 4333.3 3.64
3 neat 30 37 39 3533.3 3.55
1 neat 48 41 38 4233.3 3.63
2 neat 57 43 46 4866.7 3.69
3 neat 33 52 41 4200.0 3.62
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -1 27 30 28 28333.3 4.45
2 -1 21 25 26 24000.0 4.38
3 -1 24 29 30 27666.7 4.44
1 -1 15 16 15 15333.3 4.19
2 -1 11 13 19 14333.3 4.16
3 -1 26 21 20 22333.3 4.35
1 -1 18 13 16 15666.7 4.19
2 -1 13 11 10 11333.3 4.05
3 -1 17 12 15 14666.7 4.17
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
4468 4.14 0.07
LB
3062 4.23 0.10
3684 4.34 0.04
3.60 0.04
4468 3.65 0.04
4.48 0.05
3684 3.68 0.03
4468 4.56 0.06
Spot Count
3684 4.58 0.04
Spot Count CFU/ml
Spot Count CFU/ml
Log(CFU/ml Count)
Inocula
Replication (24 h)
Invasion (2 h)
Adhesion (1 h)
Gentamicin control (GC)
Media control (MC)
Log(CFU/ml Count
Spot Count
LB
Spot Count
3062
3062
LB
Spot Count
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B.2 S. Brandenburg infection in 24 h-old OOEC and BOEC cultures 
B.2.1  Assay (1), OOEC cultures  
 
  
Cell counting: 5.16 log 10 /ml; 15 µl of inoculum in 15ml of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 43 36 37 4.30E+09 3.60E+09 3.70E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg.(CFU/m)l Avg.log(CFU/ml) Error OD (600nm) MOI(CFU/cell)
3684 9.63 9.56 9.57 3.87E+09 9.59 0.04 0.315 27
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -2 53 58 61 5.30E+06 5.80E+06 6.10E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/ml Avg.log(CFU/ml) Error MOI Growth rate
3684 6.72 6.76 6.79 5.73E+06 6.76 0.03 40 1
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -1 60 51 53 54666.7 4.74
2 -1 57 63 59 59666.7 4.78
3 -1 47 48 48 47666.7 4.68
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 neat 14 21 23 1933.3 3.29
2 neat 41 33 33 3566.7 3.55
3 neat 26 18 20 2133.3 3.33
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -2 15 13 17 150000.0 5.18
2 -2 11 10 10 103333.3 5.01
3 -2 12 14 10 120000.0 5.08
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
3684 3.39
LB
LB
Spot Count
3684 5.09
Replication (24 h)
Spot Count CFU/ml
Log(CFU/ml Count)
Log(CFU/ml Count)
0.05
0.14
0.08
Spot Count CFU/ml
Spot Count
Spot Count
4.73
Spot Count
Inocula
Media control (MC)
Gentamicin control (GC)
Adhesion (1 h)
Invasion (2 h)
3684
LB
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B.2.2 Assay (2), OOEC cultures  
 
  
Cell counting: 5.19 log 10 /ml; 15 µl of inoculum in 15ml of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 43 36 37 4.30E+09 3.60E+09 3.70E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg.(CFU/ml) Avg.log(CFU/ml) Error OD (600nm) MOI(CFU/cell)
3684 9.63 9.56 9.57 3.87E+09 9.59 0.04 0.315 25
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -3 63 65 71 6.30E+06 6.50E+06 7.10E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.(CFU/ml) Avg.log(CFU/ml) Error MOI Growth rate
3684 6.80 6.81 6.85 6.63E+06 6.82 0.03 43 2
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -1 55 59 64 59333.3 4.77
2 -1 62 47 66 58333.3 4.77
3 -1 53 46 41 46666.7 4.67
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 neat 21 23 18 2066.7 3.32
2 neat 27 20 25 2400.0 3.38
3 neat 22 28 26 2533.3 3.40
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -2 14 12 15 136666.7 5.14
2 -2 11 10 12 110000.0 5.04
3 -2 13 19 13 150000.0 5.18
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
0.05
LB
0.07
3684 4.74 0.06
LB
Spot CountInvasion (2 h)
Media control (MC)
Gentamicin control (GC)
Adhesion (1 h)
Spot Count
LB
Spot Count
3684 5.12
Replication (24 h)
Inocula
3684 3.37
Log(CFU/ml Count)
Log(CFU/ml Count)
CFU/ml
Spot Count CFU/ml
Spot Count
Spot Count
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B.2.3 Assay (3), OOEC cultures  
 
  
Cell counting: 5.04 log 10 /ml; 15 µl of inoculum in 15ml of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 43 36 37 4.30E+09 3.60E+09 3.70E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg.(CFU/ml) Avg. log(CFU/ml) Error OD (600nm) MOI(CFU/cell)
3684 9.63 9.56 9.57 3.87E+09 9.59 0.04 0.315 35
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -2 61 63 79 6.10E+06 6.30E+06 7.90E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.OCFU/ml) Avg. log(CFU/ml) Error MOI Growth rate
3684 6.79 6.80 6.90 6.77E+06 6.83 0.06 62 2
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -1 62 67 68 65666.7 4.82
2 -1 74 71 75 73333.3 4.87
3 -1 61 59 57 59000.0 4.77
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 neat 22 21 23 2200.0 3.34
2 neat 31 32 27 3000.0 3.48
3 neat 25 29 24 2600.0 3.41
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -2 21 21 25 223333.3 5.35
2 -2 11 14 17 140000.0 5.15
3 -2 13 15 19 156666.7 5.19
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
3684 3.41 0.07
LB
LB
Spot Count
3684 5.23 0.11
Replication (24 h)
3684 4.82 0.05
LB
Spot CountInvasion (2 h)
Log(CFU/ml Count)
Log(CFU/ml Count)
Spot Count
Spot CountAdhesion (1 h)
Gentamicin control (GC)
Media control
Inocula Spot Count CFU/ml
Spot Count CFU/ml
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B.2.4 Assay (1), BOEC cultures  
 
  
Cell counting: 4.92 log 10 /ml; 15 µl of inoculum in 15ml of DMEM; 20%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 20 18 16 2.00E+09 1.80E+09 1.60E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg.(CFU/ml) Avg.log(CFU/ml) Error OD (600nm) MOI(CFU/cell)
3684 9.30 9.26 9.20 1.80E+09 9.26 0.05 0.304 22
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -3 35 31 41 3.50E+06 3.10E+06 4.10E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.(CFU/ml) Avg.log(CFU/ml) Error MOI Growth rate
3684 6.54 6.49 6.61 3.57E+06 6.55 0.06 45 2
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -1 20 17 24 20333.3 4.31
2 -1 29 28 29 28666.7 4.46
3 -1 34 28 24 28666.7 4.46
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 neat 25 27 23 2500.0 3.40
2 neat 36 23 30 2966.7 3.47
3 neat 27 25 26 2600.0 3.41
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -1 25 19 21 21666.7 4.34
2 -1 18 14 18 16666.7 4.22
3 -1 19 22 24 21666.7 4.34
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
0.04
LB
0.07
3684 4.41 0.09
LB
Spot CountInvasion (2 h)
Gentamicin control (GC)
Adhesion (1 h)
Media control (MC)
Spot Count
LB
Spot Count
3684 4.30
Replication (24 h)
Inocula
3684 3.43
Log(CFU/ml Count)
Log(CFU/ml Count)
CFU/ml
Spot Count CFU/ml
Spot Count
Spot Count
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B.2.5 Assay (2), BOEC cultures  
 
  
Cell counting : 5.2 log 10 /ml; 15 µL of inoculum in 15mL of DMEM; 20%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 57 63 49 5.70E+09 6.30E+09 4.90E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/ml Avg.log(CFU/ml) Error OD (600nm) MOI(CFU/cell)
3684 9.76 9.80 9.69 5.63E+09 9.75 0.05 0.353 36
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -3 44 54 51 4.40E+06 5.40E+06 5.10E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/ml Avg.log(CFU/ml) Error MOI Growth rate
3684 6.64 6.73 6.71 4.97E+06 6.70 0.05 32 1
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -1 56 53 51 53333.3 4.73
2 -1 57 63 65 61666.7 4.79
3 -1 44 48 53 48333.3 4.68
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain No. Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 neat 68 62 63 6433.3 3.81
2 neat 59 55 66 6000.0 3.78
3 -1 15 16 23 18000.0 4.26
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain No. Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -1 61 73 61 65000.0 4.81
2 -1 50 53 56 53000.0 4.72
3 -1 58 52 57 55666.7 4.75
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Inocula
Media control (MC)
3684 3.95 0.27
Log(CFU/ml Count)
Log(CFU/ml Count)
Spot Count
Spot Count
Gentamicin control (GC)
Adhesion (1 h)
Spot Count CFU/ml
LB
LB
Spot Count
3684 4.76
Spot Count CFU/ml
0.05
Replication (24 h)
3684 4.73 0.05
LB
Spot CountInvasion (2 h)
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B.2.6 Assay (3), BOEC cultures  
 
  
Cell counting: 5.04 log 10 /ml; 15 µL of inoculum in 15mL of DMEM; 20%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 45 42 41 4.50E+09 4.20E+09 4.10E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/ml Avg.log(CFU/ml) Error OD (600nm) MOI (CFU/cell)
3684 9.65 9.62 9.61 4.27E+09 9.63 0.02 0.295 39
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -3 53 51 62 5.30E+06 5.10E+06 6.20E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/ml Avg.log(CFU/ml) Error MOI Growth rate
3684 6.72 6.71 6.79 5.53E+06 6.74 0.04 50 1
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -1 20 15 20 18333.3 4.26
2 -1 20 26 33 26333.3 4.42
3 -1 28 31 36 31666.7 4.50
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 neat 38 26 36 3333.3 3.52
2 neat 21 26 39 2866.7 3.46
3 neat 23 23 24 2333.3 3.37
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 neat 54 59 51 5466.7 3.74
2 neat 63 66 65 6466.7 3.81
3 neat 48 44 57 4966.7 3.70
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
0.06
LB
LB
Spot Count
3684 3.75
Replication (24 h)
0.12
LB
Spot Count
3684 3.45 0.08
Invasion (2 h)
Spot Count
Spot Count
3684 4.39
Adhesion (1 h)
Gentamicin control (GC)
Log(CFU/ml Count)
Media control (MC)
Spot Count CFU/ml
Spot Count CFU/ml
Inocula
Log(CFU/ml Count)
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B.3 Salmonella infection in 7 day-old OOEC cultures 
B.3.1 Assay (1) 
 
Cells count:  5.02 log 10 /mL; 30 µL of inoculum in 15mL of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
4527 1 -5 53 41 48 5.30E+08 4.10E+08 4.80E+08
1979 1 -5 40 31 47 4.00E+08 3.10E+08 4.70E+08
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg. log(CFU/mL) Error DO (600nm) MOI
4527 8.72 8.61 8.68 4.73.E+08 8.67 0.06 0.352 30
1979 8.60 8.49 8.67 3.93.E+08 8.59 0.09 0.350 22
Strain Sample Dilution 1 2 3 1 2 3
4527 1 -4 24 22 18 2.40E+07 2.20E+07 1.80E+07
1979 1 -4 17 14 11 1.70E+07 1.40E+07 1.10E+07
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error MOI Growth rate
4527 7.38 7.34 7.26 2.13.E+07 7.33 0.06 201 7
1979 7.23 7.15 7.04 1.40.E+07 7.14 0.09 133 6
Strain Sample Dilution 1 2 3 Average Error
4527 1 neat 0 0 0 0 0
1979 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 41 33 28 340000 5.53
2 -2 35 32 33 333333 5.52
3 -2 28 37 39 346667 5.54
1 -2 57 66 65 626667 5.80
2 -2 56 59 63 593333 5.77
3 -2 56 59 68 610000 5.79
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -1 39 38 38 38333 4.58
2 -1 30 29 33 30667 4.49
3 -1 38 40 46 41333 4.62
1 -2 18 16 15 163333 5.21
2 -2 16 21 12 163333 5.21
3 -2 20 17 13 166667 5.22
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 73 81 84 793333 5.90
2 -2 75 77 70 740000 5.87
3 -2 81 77 68 753333 5.88
1 -3 17 17 13 1566667 6.19
2 -3 18 18 10 1533333 6.19
3 -3 19 19 12 1666667 6.22
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Spot Count
5.88
LB
4527
1979
LB
4527
1979
LB
4527
1979
5.22
Invasion (2 h)
Replication(24 h)
0.02
6.20 0.02
Log(CFU/ml Count)
Spot Count
Spot Count
0.01
Spot Count
5.53 0.01
5.79 0.01
4.56 0.07
Gentamicin control (GC)
Adhesion (1 h)
Spot Count CFU/ml
Log(CFU/ml Count)
Spot Count CFU/ml
Inocula 
Media control (MC)
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Cell counting: 5.20 log 10 /ml; 15 µL of inoculum in 15mL of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 8 7 8 8.00E+08 7.00E+08 8.00E+08
3062 1 -6 6 7 5 6.00E+08 7.00E+08 5.00E+08
4468 1 -6 3 6 4 3.00E+08 6.00E+08 4.00E+08
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/ml Avg.log(CFU/ml) Error OD (600nm) MOI(CFU/cell)
3684 8.90 8.85 8.90 7.67E+08 8.88 0.03 0.391 24
3062 8.78 8.85 8.70 6.00E+08 8.78 0.07 0.371 19
4468 8.48 8.78 8.60 4.33E+08 8.64 0.15 0.327 14
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -4 9 10 7 9.00E+06 1.00E+07 7.00E+06
3062 1 -4 7 5 5 7.00E+06 5.00E+06 5.00E+06
4468 1 -4 6 4 6 6.00E+06 4.00E+06 6.00E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/ml Avg. log(CFU/ml) Error MOI (CFU/cell) Growth rate
3684 6.95 7.00 6.85 8.67E+06 6.94 0.08 54 2
3062 6.85 6.70 6.70 5.67E+06 6.75 0.08 42 2
4468 6.78 6.60 6.78 5.33E+06 6.73 0.10 42 3
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
3062 1 neat 0 0 0 0 0
4468 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -3 11 22 14 1566666.7 6.19
2 -3 6 5 8 633333.3 5.80
3 -3 5 2 10 566666.7 5.75
1 -3 3 8 5 533333.3 5.73
2 -3 6 2 2 333333.3 5.52
3 -3 7 12 7 866666.7 5.94
1 -3 1 4 1 200000.0 5.30
2 -3 2 1 1 133333.3 5.12
3 -3 3 2 2 233333.3 5.37
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -2 11 12 15 12666.7 4.10
2 -2 15 10 21 15333.3 4.19
3 -2 23 15 19 19000.0 4.28
1 -2 22 24 27 24333.3 4.39
2 -2 15 13 20 16000.0 4.20
3 -2 16 15 19 16666.7 4.22
1 -2 12 12 21 15000.0 4.18
2 -2 17 11 13 13666.7 4.14
3 -2 22 23 20 21666.7 4.34
1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/ml Log10 Average Error
1 -3 2 3 6 366666.7 5.56
2 -3 3 2 5 333333.3 5.52
3 -3 4 5 8 566666.7 5.75
1 -3 2 4 1 233333.3 5.37
2 -3 5 6 7 600000 5.78
3 -3 7 6 7 666666.7 5.82
1 -3 14 15 15 1466666.7 6.17
2 -3 12 19 6 1233333.3 6.09
3 -3 14 16 13 1433333.3 6.16
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
inocula 
Media control (MC)
Log(CFU/ml Count)
Spot Count CFU/ml
Spot Count CFU/ml
3062 5.73 0.21
Adhesion (1 h)
Log(CFU/ml Count
Gentamicin control (GC) Spot Count
Spot Count
3684 5.92
LB
Spot Count
3684 4.19 0.09
Invasion (2 h)
LB
0.04
Spot Count
3684 5.49 0.12
Replication (24 h)
4468 6.14
3062 5.66 0.25
4468 5.26 0.13
4468 4.22 0.11
3062 4.27 0.10
LB
0.24
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B.3.2 Assay (2) 
 
  
Cells count:  5.0 log 10 /mL; 30 µL of inoculum in 15mL of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
4527 1 -5 53 41 48 5.30E+08 4.10E+08 4.80E+08
1979 1 -5 40 31 47 4.00E+08 3.10E+08 4.70E+08
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error DO (600nm) MOI
4527 8.72 8.61 8.68 4.73.E+08 8.67 0.06 0.352 32
1979 8.60 8.49 8.67 3.93.E+08 8.59 0.09 0.350 26
Strain Sample Dilution 1 2 3 1 2 3
4527 1 -4 25 27 23 2.50E+07 2.70E+07 2.30E+07
1979 1 -4 20 15 11 2.00E+07 1.50E+07 1.10E+07
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error MOI Growth rate
4527 7.40 7.43 7.36 2.50.E+07 7.40 0.03 250 8
1979 7.30 7.18 7.04 1.53.E+07 7.17 0.13 153 6
Strain Sample Dilution 1 2 3 Average Error
4527 1 neat 0 0 0 0 0
1979 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 31 35 39 350000 5.54
2 -2 21 18 25 213333 5.33
3 -2 18 17 31 220000 5.34
1 -2 51 40 41 440000 5.64
2 -2 35 33 35 343333 5.54
3 -2 39 50 45 446667 5.65
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -1 38 33 37 36000 4.56
2 -1 35 37 31 34333 4.54
3 -1 42 41 45 42667 4.63
1 -2 11 14 10 116667 5.07
2 -2 12 11 10 110000 5.04
3 -2 10 10 11 103333 5.01
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 52 53 47 506667 5.70
2 -2 80 71 63 713333 5.85
3 -2 56 52 51 530000 5.72
1 -3 15 12 22 1633333 6.21
2 -3 13 10 12 1166667 6.07
3 -3 13 10 10 1100000 6.04
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Spot Count
5.76
LB
4527
1979
LB
4527
1979
LB
4527
1979
5.04
Invasion (2 h)
Replication(24 h)
0.08
6.11 0.09
Log(CFU/ml Count)
Spot Count
Spot Count
0.03
Spot Count
5.41 0.12
5.61 0.06
4.57 0.05
Gentamicin control (GC)
Adhesion (1 h)
Spot Count CFU/ml
Log(CFU/ml Count)
Spot Count CFU/ml
Inocula 
Media control (MC)
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Cells count:  5.18 log 10 /mL; 15 µL of inoculum in 15mL of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -5 50 48 56 5.00E+08 4.80E+08 5.60E+08
3062 1 -5 51 43 45 5.10E+08 4.30E+08 4.50E+08
4468 1 -5 40 40 39 4.00E+08 4.00E+08 3.90E+08
LB 1 neat 0 0 0
Strain 1 2 3 Avg. CFU/mL Avg.log(CFU/mL) Error DO (600nm) MOI (CFU/cell)
3684 8.70 8.68 8.75 5.13.E+08 8.71 0.03 0.476 23
3062 8.71 8.63 8.65 4.63.E+08 8.66 0.04 0.358 21
4468 8.60 8.60 8.59 3.97.E+08 8.60 0.01 0.363 18
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -3 57 63 60 5.70E+06 6.30E+06 6.00E+06
3062 1 -3 70 63 66 7.00E+06 6.30E+06 6.60E+06
4468 1 -3 49 54 58 4.90E+06 5.40E+06 5.80E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error MOI (CFU/cell) Growth rate
3684 6.76 6.80 6.78 6.00.E+06 6.78 0.02 45 2
3062 6.85 6.80 6.82 6.63.E+06 6.82 0.02 45 2
4468 6.69 6.73 6.76 5.37.E+06 6.73 0.04 45 3
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
3062 1 neat 0 0 0 0 0
4468 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 40 38 35 376667 5.58
2 -2 30 36 32 326667 5.51
3 -2 37 38 34 363333 5.56
1 -2 37 38 33 360000 5.56
2 -2 39 40 43 406667 5.61
3 -2 38 39 37 380000 5.58
1 -2 28 36 33 323333 5.51
2 -2 22 31 28 270000 5.43
3 -2 33 32 33 326667 5.51
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -1 46 53 55 51333 4.71
2 -1 54 58 60 57333 4.76
3 -1 68 65 70 67667 4.83
1 -1 68 67 63 66000 4.82
2 -1 57 53 51 53667 4.73
3 -1 48 49 60 52333 4.72
1 -1 32 34 40 35333 4.55
2 -1 24 22 25 23667 4.37
3 -1 32 32 37 33667 4.53
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 21 19 20 200000 5.30
2 -2 25 20 24 230000 5.36
3 -2 28 22 30 266667 5.43
1 -2 26 27 28 270000 5.43
2 -2 24 27 29 266667 5.43
3 -2 26 26 30 273333 5.44
1 -2 70 75 69 713333 5.85
2 -2 63 66 64 643333 5.81
3 -2 60 59 61 600000 5.78
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
3684
LB
3062 4.76
Spot Count
3684 5.36
LB
Replication(24 h)
5.58
0.06
4468 4.48 0.10
4468 5.49 0.05
LB
Spot Count
3684 4.77 0.06
Invasion (2 h)
0.03
Spot Count CFU/ml
Log(CFU/ml Count)
Spot Count CFU/ml
Log(CFU/ml Count)
Spot Count
Spot Count
5.55 0.03
Adhesion (1 h)
Gentamicin (All)
Media control
Inocula 
3062
0.06
3062 5.43 0.01
4468 5.81 0.04
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B.3.3 Assay (3) 
 
Cells count:  5.0 log 10 /mL; 30 µL of inoculum in 15mL of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
4527 1 -5 68 60 67 6.80E+08 6.00E+08 6.70E+08
1979 1 -5 32 33 29 3.20E+08 3.30E+08 2.90E+08
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error DO (600nm) MOI
4527 8.83 8.78 8.83 6.50.E+08 8.81 0.03 0.366 22
1979 8.51 8.52 8.46 3.13.E+08 8.50 0.03 0.316 10
Strain Sample Dilution 1 2 3 1 2 3
4527 1 -3 70 62 65 7.00E+06 6.20E+06 6.50E+06
1979 1 -3 29 32 34 2.90E+06 3.20E+06 3.40E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error MOI Growth rate
4527 6.85 6.79 6.81 6.57.E+06 6.82 0.03 66 3
1979 6.46 6.51 6.53 3.17.E+06 6.50 0.03 32 3
Strain Sample Dilution 1 2 3 Average Error
4527 1 neat 0 0 0 0 0
1979 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 32 28 30 300000 5.48
2 -2 21 15 28 213333 5.33
3 -2 30 33 35 326667 5.51
1 -3 51 50 54 516667 5.71
2 -3 59 61 63 610000 5.79
3 -3 50 58 51 530000 5.72
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -1 28 37 31 32000 4.51
2 -1 51 40 44 45000 4.65
3 -1 31 26 34 30333 4.48
1 -2 18 20 23 203333 5.31
2 -2 29 30 26 283333 5.45
3 -2 25 21 27 243333 5.39
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 65 63 61 630000 5.80
2 -2 61 67 74 673333 5.83
3 -2 72 72 66 700000 5.85
1 -3 13 11 14 1266667 6.10
2 -3 12 15 14 1366667 6.14
3 -3 11 10 12 1100000 6.04
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
1979 6.09 0.05
LB
Spot Count
4527 5.82 0.02
4527 4.55 0.09
1979 5.38 0.07
LB
Spot Count
Invasion (2 h)
Replication(24 h)
0.10
1979 5.74 0.04
LB
Log(CFU/ml Count)
Spot Count
Spot Count
4527 5.44
Gentamicin control (GC)
 Adhesion (1 h)
Spot Count CFU/ml
Log(CFU/ml Count)
Spot Count CFU/ml
Inocula 
Media control (MC)
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Cells count:  5.02 log 10 /mL; 15 µL of inoculum in 25mL of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -5 44 46 41 4.40E+08 4.60E+08 4.10E+08
3062 1 -5 57 53 55 5.70E+08 5.30E+08 5.50E+08
4468 1 -5 15 15 18 1.50E+08 1.50E+08 1.80E+08
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error DO (600nm) MOI
3684 8.64 8.66 8.61 4.37.E+08 8.64 0.03 0.280 17
3062 8.76 8.72 8.74 5.50.E+08 8.74 0.02 0.323 21
4468 8.18 8.18 8.26 1.60.E+08 8.20 0.05 0.205 6
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -3 25 22 28 2.50E+06 2.20E+06 2.80E+06
3062 1 -3 32 23 38 3.20E+06 2.30E+06 3.80E+06
4468 1 -3 13 21 17 1.30E+06 2.10E+06 1.70E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg. log(CFU/mL) Error MOI Growth rate
3684 6.40 6.34 6.45 2.50.E+06 6.40 0.05 24 1
3062 6.51 6.36 6.58 3.10.E+06 6.48 0.11 30 1
4468 6.11 6.32 6.23 1.70.E+06 6.22 0.10 11 2
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
3062 1 neat 0 0 0 0 0
4468 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 67 73 65 683333 5.83
2 -2 64 61 70 650000 5.81
3 -2 63 59 60 606667 5.78
1 -2 39 64 43 486667 5.69
2 -2 37 33 40 366667 5.56
3 -2 73 71 69 710000 5.85
1 -2 51 58 53 540000 5.73
2 -2 51 57 68 586667 5.77
3 -2 63 64 73 666667 5.82
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 31 20 28 263333 5.42
2 -2 30 33 25 293333 5.47
3 -2 23 30 28 270000 5.43
1 -2 24 23 30 256667 5.41
2 -2 20 20 23 210000 5.32
3 -2 25 21 20 220000 5.34
1 -2 15 10 13 126667 5.10
2 -2 12 12 15 130000 5.11
3 -2 11 20 15 153333 5.19
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -3 23 12 11 1533333 6.19
2 -3 16 20 18 1800000 6.26
3 -3 23 33 27 2766667 6.44
1 -3 10 10 14 1133333 6.05
2 -3 16 17 18 1700000 6.23
3 -3 19 11 12 1400000 6.15
1 -3 38 41 36 3833333 6.58
2 -3 31 30 23 2800000 6.45
3 -3 44 38 35 3900000 6.59
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
CFU/ml
Log(CFU/ml Count)
Spot Count CFU/ml
3684 5.44
Invasion (2 h)
Log(CFU/ml Count)
Inocula 
Media control (MC)
Gentamicin control (GC)
Adhesion (1 h)
Spot Count
0.02
Spot Count
Spot Count
3684 5.81 0.03
3062 5.70 0.14
4468 5.77 0.05
LB
Spot Count
3062 6.14 0.09
3062 5.36 0.05
4468 5.13 0.05
LB
Spot Count
3684 6.29 0.13
Replication(24 h)
4468 6.54 0.08
LB
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B.4 S. Brandenburg infection in 7 day-old OOEC and BOEC cultures 
B.4.1 Assay (1), OOEC cultures  
 
  
Cells count:  5.08 log 10 /mL; 30 µL of inoculum in 15mL of DMEM; 20%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 11 15 10 1.10E+09 1.50E+09 1.00E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg.FU/mL Avg.log(CFU/mL) Error DO (600nm) MOI
3684 9.04 9.18 9.00 1.20.E+09 9.07 0.09 0.348 50
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -4 17 14 21 1.70E+07 1.40E+07 2.10E+07
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error MOI Growth rate
3684 7.23 7.15 7.32 1.73.E+07 7.23 0.09 144 3
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 44 35 38 390000 5.59
2 -2 30 33 37 333333 5.52
3 -2 38 31 30 330000 5.52
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 29 30 27 286667 5.46
2 -2 28 22 25 250000 5.40
3 -2 30 25 30 283333 5.45
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 31 34 38 343333 5.54
2 -2 30 28 22 266667 5.43
3 -2 24 27 31 273333 5.44
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
LB
LB
Spot Count
3684 5.47
Replication(24 h)
Log(CFU/ml Count)
0.06
3684 5.44 0.03
Spot Count
Spot Count
3684 5.54 0.04
LB
Spot Count
Gentamicin control (GC)
Adhesion (1 h)
Invasion (2 h)
Spot Count CFU/ml
Log(CFU/ml Count)
Spot Count CFU/ml
Inocula 
Media control (MC)
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B.4.2 Assay (2), OOEC cultures  
 
  
Cells count:  5.08 log 10 /mL; 30 µL of inoculum in 15mL of DMEM; 20%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -5 53 58 55 5.30E+08 5.80E+08 5.50E+08
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error DO (600nm) MOI
3684 8.72 8.76 8.74 5.53.E+08 8.74 0.02 0.370 23
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -3 37 31 35 3.70E+06 3.10E+06 3.50E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error MOI Growth rate
3684 6.57 6.49 6.54 3.43.E+06 6.53 0.04 29 1
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 30 37 35 340000 5.53
2 -2 40 30 32 340000 5.53
3 -2 41 33 43 390000 5.59
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 27 26 22 250000 5.40
2 -2 26 25 30 270000 5.43
3 -2 21 23 21 216667 5.34
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -3 67 68 58 6433333 6.81
2 -3 11 17 14 1400000 6.15
3 -3 35 38 40 3766667 6.58
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
0.34
LB
Spot Count
3684 5.39 0.05
LB
Spot Count
3684 6.51
Invasion (2 h)
Replication(24 h)
Spot Count CFU/ml
Log(CFU/ml Count)
5.55 0.03
Inocula 
Media control (MC)
Gentamicin (All)
Adhesion (1 h)
Spot Count CFU/ml
Log(CFU/ml Count)
LB
Spot Count
Spot Count
3684
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B.4.3 Assay (3), OOEC cultures  
 
  
Cells count:  5.02 log 10 /mL; 30 µL of inoculum in 15mL of DMEM; 20%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -5 53 58 55 5.30E+08 5.80E+08 5.50E+08
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error DO (600nm) MOI
3684 8.72 8.76 8.74 5.53.E+08 8.74 0.02 0.370 26
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -3 30 37 35 3.00E+06 3.70E+06 3.50E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error MOI Growth rate
3684 6.48 6.57 6.54 3.40.E+06 6.53 0.05 32 1
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 44 40 37 403333 5.61 0.06
2 -2 55 52 55 540000 5.73
3 -2 45 50 48 476667 5.68
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 36 38 35 363333 5.56 0.05
2 -2 35 25 32 306667 5.49
3 -2 30 31 25 286667 5.46
LB 1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -3 31 36 38 3500000 6.54 0.13
2 -3 27 36 26 2966667 6.47
3 -3 16 20 22 1933333 6.29
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
LB
LB
Inocula 
Media control (MC)
Gentamicin control (GC)
 Adhesion (1 h)
Invasion (2 h)
Replication(24 h)
3684
3684
Log(CFU/ml Count)
Spot Count
Spot Count
CFU/ml
3684
Spot Count
Spot Count CFU/ml
Log(CFU/ml Count)
Spot Count
Spot Count
6.43
5.50
5.67
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B.4.4 Assay (1), BOEC cultures  
 
  
Cells count:  5.13 log 10 /mL; 30 µL of inoculum in 15mL of DMEM; 20%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 10 10 13 1.00E+09 1.00E+09 1.30E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error DO (600nm) MOI
3684 9.00 9.00 9.11 1.10.E+09 9.04 0.07 0.348 44
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -4 17 14 18 1.70E+07 1.40E+07 1.80E+07
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error MOI Growth rate
3684 7.23 7.15 7.26 1.63.E+07 7.21 0.06 121 3
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 40 43 39 406667 5.61
2 -2 35 37 32 346667 5.54
3 -2 32 31 40 343333 5.54
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 19 15 20 180000 5.26
2 -2 30 24 29 276667 5.44
3 -2 20 17 15 173333 5.24
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 37 34 26 323333 5.51
2 -2 33 36 32 336667 5.53
3 -2 24 21 28 243333 5.39
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
LB
LB
Spot Count
3684 5.47
Replication(24 h)
Log(CFU/ml Count)
0.08
3684 5.31 0.11
Spot Count
Spot Count
3684 5.56 0.04
LB
Spot Count
Gentamicin control (GC)
Adhesion (1 h)
Invasion (2 h)
Spot Count CFU/ml
Log(CFU/ml Count)
Spot Count CFU/ml
Inocula 
Media control (MC）
125 
 
B.4.5 Assay (2), BOEC cultures  
 
  
Cells count:  5.15 log 10 /mL; 15 µL of inoculum in 15mL of DMEM; 20%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 12 16 13 1.20E+09 1.60E+09 1.30E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error DO (600nm) MOI
3684 9.08 9.20 9.11 1.37.E+09 9.13 0.06 0.320 33
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -4 15 16 14 1.50E+07 1.60E+07 1.40E+07
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error MOI Growth rate
3684 7.18 7.20 7.15 1.50.E+07 7.18 0.03 107 3
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 53 63 57 576667 5.76
2 -2 56 59 61 586667 5.77
3 -2 51 62 58 570000 5.76
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 30 32 35 323333 5.51
2 -2 38 41 32 370000 5.57
3 -2 36 38 42 386667 5.59
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 62 61 60 610000 5.79
2 -2 52 58 46 520000 5.72
3 -2 55 50 44 496667 5.70
1 -1 3 0 0
2 -1 4 0 0
3 -1 6 0 0
LB
LB
Spot Count
3684 5.73
Replication(24 h)
Log(CFU/ml Count)
0.05
3684 5.56 0.04
Spot Count
Spot Count
3684 5.76 0.01
LB
Spot Count
Gentamicin control (GC)
Adhesion (1 h)
Invasion (2 h)
Spot Count CFU/ml
Log(CFU/ml Count)
Spot Count CFU/ml
Inocula 
Media control (MC)
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B.4.6 Assay (3), BOEC cultures  
 
  
Cells count:  5.30 log 10 /mL; 15 µL of inoculum in 25mL of DMEM; 20%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 12 16 13 1.20E+09 1.60E+09 1.30E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error DO (600nm) MOI
3684 9.08 9.20 9.11 1.37.E+09 9.13 0.06 0.320 23
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -4 12 20 11 1.20E+07 2.00E+07 1.10E+07
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error MOI Growth rate
3684 7.08 7.30 7.04 1.43.E+07 7.14 0.14 72 3
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 53 61 64 593333 5.77
2 -2 60 63 69 640000 5.81
3 -2 60 67 71 660000 5.82
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 41 40 38 396667 5.60
2 -2 39 43 45 423333 5.63
3 -2 37 40 44 403333 5.61
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 58 46 49 510000 5.71
2 -2 44 41 45 433333 5.64
3 -2 45 47 43 450000 5.65
1 -1 0 0 0
2 -1 0 0 0
3 -1 0 0 0
LB
LB
Spot Count
3684 5.67
Replication(24 h)
Log(CFU/ml Count)
0.04
3684 5.61 0.01
Spot Count
Spot Count
3684 5.80 0.02
LB
Spot Count
Gentamicin (All)
Adhesion(1 h)
Invasion (2 h)
Spot Count CFU/ml
Log(CFU/ml Count)
Spot Count CFU/ml
Inocula (All)
Media (All)
127 
 
B.5 S. Brandenburg infection in 7 day-old OIEC cultures 
B.5.1 Assay (1) 
 
Cells count:  4.99 log 10 /mL; 15 µL of inoculum in 15mL of DMEM; 10%FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 31 25 30 3.10E+09 2.50E+09 3.00E+09
1979 1 -6 11 15 10 1.10E+08 1.50E+08 1.00E+08
LB 1 neat 0 0 0
Strain 1 2 3 Avg.(CFU/ml) Avg.log(CFU/ml) Error DO (600nm) MOI
3684 9.49 9.40 9.48 2.87.E+09 9.46 0.05 0.302 29
1979 8.04 8.18 8.00 1.20.E+08 8.07 0.09 0.296 12
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -3 52 55 56 5.20E+06 5.50E+06 5.60E+06
1979 1 -3 26 27 22 2.60E+06 2.70E+06 2.20E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.(CFU/ml) Avg.log(CFU/ml) Error MOI Growth rate
3684 6.72 6.74 6.75 5.43.E+06 6.73 0.02 55 2
1979 6.41 6.43 6.34 2.50.E+06 6.40 0.05 26 2
Strain No. Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
1979 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Avg Error
1 -2 41 35 38 380000 5.58
2 -2 40 43 37 400000 5.60
3 -2 38 41 40 396667 5.60
1 -2 12 10 14 120000 5.08
2 -2 22 24 26 240000 5.38
3 -2 23 20 21 213333 5.33
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Avg Error
1 -1 19 20 27 22000 4.34
2 -1 18 12 15 15000 4.18
3 -1 20 15 20 18333 4.26
1 neat 84 86 89 8633 3.94
2 neat 84 80 87 8367 3.92
3 neat 82 87 86 8500 3.93
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Avg Error
1 -2 21 24 18 210000 5.32
2 -2 27 24 22 243333 5.39
3 -2 14 17 31 206667 5.32
1 -2 10 10 11 103333 5.01
2 -2 10 11 12 110000 5.04
3 -2 11 10 10 103333 5.01
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
1979 5.02 0.02
LB
LB
Spot Count
3684 5.34 0.04
Replication (24 h)
1979 3.93 0.01
1979 5.26 0.16
LB
Spot Count
3684 4.26 0.08
Invasion (2 h)
Spot Count
Spot Count
3684 5.59 0.01
Gentamicin control (GC)
Adhesion (1 h)
Log(CFU/ml Count)
Spot Count CFU/ml
Log(CFU/ml Count)
Spot Count CFU/mlMedia control (MC)
Inocula 
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B.5.2 Assay (2) 
 
  
Cells count:  5.06 log 10 /mL; 15 µL of inoculum in 15mL of DMEM; 10% FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 31 25 30 3.10E+09 2.50E+09 3.00E+09
1979 1 -6 11 15 10 1.10E+08 1.50E+08 1.00E+08
LB 1 neat 0 0 0
Strain 1 2 3 Avg.(CFU/ml） Avg.log(CFU/ml) Error DO (600nm) MOI
3684 9.49 9.40 9.48 2.87.E+09 9.46 0.05 0.3 25
1979 8.04 8.18 8.00 1.20.E+08 8.07 0.09 0.303 10
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -3 61 55 50 6.10E+06 5.50E+06 5.00E+06
1979 1 -3 35 32 30 3.50E+06 3.20E+06 3.00E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg.CFU/mL Avg.log(CFU/mL) Error MOI Growth rate
3684 6.79 6.74 6.70 5.53.E+06 6.74 0.04 48 2
1979 6.54 6.51 6.48 3.23.E+06 6.51 0.03 28 3
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
1979 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 44 45 48 456667 5.66
2 -2 40 43 47 433333 5.64
3 -2 48 51 40 463333 5.67
1 -2 32 33 32 323333 5.51
2 -2 21 25 20 220000 5.34
3 -2 30 30 22 273333 5.44
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -1 19 23 27 23000 4.36
2 -1 28 12 24 21333 4.33
3 -1 17 25 25 22333 4.35
1 -1 15 13 17 15000 4.18
2 -1 15 15 16 15333 4.19
3 -1 10 11 12 11000 4.04
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Average Error
1 -2 41 44 38 410000 5.61
2 -2 40 37 42 396667 5.60
3 -2 34 37 41 373333 5.57
1 -2 11 12 12 116667 5.07
2 -2 10 12 15 123333 5.09
3 -2 11 10 10 103333 5.01
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
1979 5.06 0.04
LB
LB
Spot Count
3684 5.59 0.02
Replication (24 h)
1979 4.13 0.08
1979 5.43 0.08
LB
Spot Count
3684 4.35 0.02
Invasion (2 h)
Spot Count
Spot Count
3684 5.65 0.02
Gentamicin control (GC)
Adhesion (1 h)
Log(CFU/ml Count)
Spot Count CFU/ml
Log(CFU/ml Count)
Spot Count CFU/mlMedia control (MC)
Inocula 
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B.5.3 Assay (3) 
 
  
Cells count:   5.01 log 10 /mL; 15 µL of inoculum in 15mL of DMEM; 10% FBS
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -6 31 25 30 3.10E+09 2.50E+09 3.00E+09
1979 1 -6 11 15 10 1.10E+09 1.50E+09 1.00E+09
LB 1 neat 0 0 0
Strain 1 2 3 Avg. (CFU/ml) Avg.log(CFU/ml) Error DO (600nm) MOI
3684 9.49 9.40 9.48 2.87.E+09 9.46 0.05 0.302 28
1979 9.04 9.18 9.00 1.20.E+09 9.07 0.09 0.296 12
Strain Sample Dilution 1 2 3 1 2 3
3684 1 -3 73 63 84 7.30E+06 6.30E+06 8.40E+06
1979 1 -3 21 23 32 2.10E+06 2.30E+06 3.20E+06
LB 1 neat 0 0 0
Strain 1 2 3 Avg. (CFU/ml) Avg. log(CFU/ml) Error MOI Growth rate
3684 6.86 6.80 6.92 7.33.E+06 6.86 0.06 71 3
1979 6.32 6.36 6.51 2.53.E+06 6.40 0.10 25 2
Strain Sample Dilution 1 2 3 Average Error
3684 1 neat 0 0 0 0 0
1979 1 neat 0 0 0 0 0
LB 1 neat 0 0 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Avg Error
1 -2 46 51 45 473333 5.68
2 -2 42 39 44 416667 5.62
3 -2 45 47 41 443333 5.65
1 -2 14 13 11 126667 5.10
2 -2 15 16 12 143333 5.16
3 -2 16 24 19 196667 5.29
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Avg Error
1 -1 24 28 27 26333 4.42
2 -1 33 25 25 27667 4.44
3 -1 23 25 30 26000 4.41
1 -1 10 11 12 11000 4.04
2 -1 12 11 11 11333 4.05
3 -1 10 10 11 10333 4.01
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Strain Sample Dilution 1 2 3 CFU/mL Log10 Avg Error
1 -2 21 24 28 243333 5.39
2 -2 20 28 23 236667 5.37
3 -2 25 27 21 243333 5.39
1 -2 20 22 24 220000 5.34
2 -2 28 21 22 236667 5.37
3 -2 28 23 17 226667 5.36
1 neat 0 0 0
2 neat 0 0 0
3 neat 0 0 0
Adhesion (1 h)
Invasion (2 h)
1979 5.36 0.02
0.01
1979 4.04 0.02
1979 5.18 0.10
LB
Spot Count
3684
LB
LB
Spot Count
3684 5.38
Replication (24 h)
4.43 0.01
Spot Count
Spot Count
3684 5.65 0.03
Gentamicin control (GC)
Log(CFU/ml Count)
Spot Count CFU/ml
Log(CFU/ml Count)
Spot Count CFU/ml
Inocula 
Media control (MC)
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     Appendix C 
Analysis of the effects of Salmonella infection 
The tables display the Wald statistic tests for null effect. These statistics are approximately 
distributed as an F distribution with degrees of freedom calculated from the stratum variances 
(See Guide to Genstat, 2009). Significant P values for Wald tests indicate that means are 
significantly different; particular pairs of means are tested with t-tests. 
 
C.1 Analysis of the effects of Salmonella infection in 24 h-old OOEC 
cultures [Genstat REML (Payne, et al., 2009)]. 
Fixed term Wald statistic n.d.f. F statistic d.d.f F pr 
Isolate 42.95 4 10.74 8.0 0.003 
Time_h 1458.11 2 729.05 350.0 <0.001 
Isolate.time_h 112.12 8 14.01 350.0 <0.001 
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C.2 Analysis of the effects of S. Brandenburg infection in 24 h-old OOEC 
and BOEC cultures 
Fixed term Wald statistic d.f. Wald/d.f. Chi pr 
Isolate 0.00 0 * * 
Time_h 1214.03 2 607.02 <0.001 
Species 90.41 1 90.41 <0.001 
Isolate.time_h 0.00 0 * * 
Isolate.species 0.00 0 * * 
Time_h.species 197.85 2 98.92 <0.001 
Isolate.time_h.species 0.00 0 * * 
 
 
 
 
 
 
C.3 Analysis of the effects of Salmonella infection in 7 day-old OOEC 
cultures  
Fixed term Wald statistic n.d.f. F statistic d.d.f F pr 
Isolate 26.48 4 6.62 8.0 0.012 
Time_h 1593.09 2 796.55 350.0 <0.001 
Isolate.time_h 188.19 8 23.52 350.0 <0.001 
 
  
132 
 
C.4 Analysis of the effects of S. Brandenburg infection in 7 day-old OOEC 
and BOEC cultures 
Fixed term Wald statistic d.f. Wald/d.f. Chi pr 
Isolate 0.00 0 * * 
Time_h 79.16 2 39.58 <0.001 
Species 34.09 1 34.09 <0.001 
Isolate.time_h 0.00 0 * * 
Isolate.species 0.00 0 * * 
Time_h.species 104.96 2 52.48 <0.001 
Isolate.time_h.species 0.00 0 * * 
 
 
 
 
C.5 Analysis of the effect of S. Brandenburg infection in 7 day-old OIEC 
and OOEC cultures 
Fixed term Wald statistic d.f. Wald/d.f. Chi pr 
Isolate 0.00 0 * * 
Time_h 586.71 2 293.35 <0.001 
Cell_line 130.20 1 130.20 <0.001 
Isolate.time_h 0.00 0 * * 
Isolate.cell_line 0.00 0 * * 
Time_h.cell_line 63.94 2 31.97 <0.001 
Isolate.time_h.cell_line 0.00 0 * * 
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     Appendix D  
Graphical tests of residuals 
Histogram should display a normal distribution-bell-shaped curve in order to apply parametric 
analysis. The Fitted-value plot should show equal variation across the values of fitted values 
(usually means). The Normal plot (sometimes called a Q-Q plot) should show a straight line if 
the distribution is normal; likewise the Half-normal plot. 
D.1 Salmonella infection in 24 h-old OOEC cultures 
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D.2 S. Brandenburg infection in 24 h-old OOEC and BOEC cultures 
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D.3 Salmonella infection in 7 day-old OOEC cultures  
 
  
Half-Normal plot
Histogram of residuals Fitted-value plot
Normal plot
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D.4 S. Brandenburg infection in 7 day-old OOEC and BOEC cultures 
 
  
Half-Normal plot
Histogram of residuals Fitted-value plot
Normal plot
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D.5 S. Brandenburg infection in 7 day-old OIEC and OOEC cultures 
 
 
Half-Normal plot
Histogram of residuals Fitted-value plot
Normal plot
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